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Abstract: Due to the proliferative cancer rates, cardiovascular diseases, neurodegenerative disorders,
autoimmune diseases and a plethora of infections across the globe, it is essential to introduce strategies
that can rapidly and specifically detect the ultralow concentrations of relevant biomarkers, pathogens,
toxins and pharmaceuticals in biological matrices. Considering these pathophysiologies, various
research works have become necessary to fabricate biosensors for their early diagnosis and treatment,
using nanomaterials like quantum dots (QDs). These nanomaterials effectively ameliorate the sensor
performance with respect to their reproducibility, selectivity as well as sensitivity. In particular,
graphene quantum dots (GQDs), which are ideally graphene fragments of nanometer size, constitute
discrete features such as acting as attractive fluorophores and excellent electro-catalysts owing to
their photo-stability, water-solubility, biocompatibility, non-toxicity and lucrativeness that make
them favorable candidates for a wide range of novel biomedical applications. Herein, we reviewed
about 300 biomedical studies reported over the last five years which entail the state of art as well as
some pioneering ideas with respect to the prominent role of GQDs, especially in the development
of optical, electrochemical and photoelectrochemical biosensors. Additionally, we outline the ideal
properties of GQDs, their eclectic methods of synthesis, and the general principle behind several
biosensing techniques.
Keywords: graphene quantum dots (GQDs); nanomaterials; biosensors; optical sensors; electrochemical
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1. Introduction
Cancer and cardiovascular disorders are becoming the leading causes of death all over the world.
In 2018, a global statistical estimation of around 9.6 million human deaths and 18.1 million cancer cases
was reported [1], whereas cardiovascular disorders result in nearly 66% of deaths that account for
considerable rates of mortality and morbidity [2,3]. Contemporaneously, various neurodegenerative
diseases, autoimmune disorders and infectious diseases are threatening modern health care system.
Considering the severity of such pathophysiologies as well as their dramatic rise, researchers have
zeroed in on the breakthrough inventions of several portable as well as versatile sensing systems for the
speedy, highly selective and quite specific determination of the target biomolecules in environmental
and clinical areas. Early sensing of these analytes is a key step toward abolishing metastasis, adapting
dynamic therapies and preventing fatality. Despite the availability of several conventional culturing
methods for sensing target analytes, their limitations reside in tedious and time-consuming procedures,
expensive instrumentation, highly skilled manpower, low sensitivity and impotency to perform in-field
monitoring. Henceforth, there is a huge demand to achieve an on-site detection of target biomolecules
in biological media and thereby to contrive the necessary precautions for their effective inactivation.
This has now become remarkably convenient by virtue of biosensor development.
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1.1. History, Definition and Classification of Biosensors
In 1962, Clark and Lyons invented the very first biosensor that was an amperometric enzyme-based
sensor for monitoring glucose levels [4]. Since then, biosensors have garnered tremendous attention
for biomedical applications, especially for drug discovery, disease monitoring and quantification of
target analytes. These analytes generally include microorganisms (i.e., viruses, bacteria, fungi, etc.),
biomarkers responsible for causing certain diseases, environmental toxins, pollutants, allergens and
metal ions. The reminiscent biosensors are reported to determine these target analytes in biological
matrices including human blood, sweat, saliva, urine, food products, environmental samples, etc. [5–10].
Biosensors are analytical tools comprising a biological recognition element and a suitable transducer
that are usually connected to an appropriate data-processing system [11]. These sensors integrate
a biological element with a physiochemical transducer to generate an electronic signal, which is
directly proportional to the analyte concentration and subsequently conveyed to a detector [12].
Generally, the classification of biosensors depends on: (a) the type of receptors employed during the
bio-recognition events, such as antibody [13], peptide [14], enzyme [15,16] aptamer [17], DNA [18]
and molecularly imprinted polymer (MIP)-based sensors [19,20]; (b) the type of transducers involved,
such as electrochemical [21], optical [22], piezoelectric [23] and calorimetric biosensors [24]. They
can accomplish the requirements of rapid and specific sensing of the biomolecules as well as the
real-time analysis of modern detection techniques. Thus, it is speculated that these sensing platforms
can provide abundant opportunities for research and development.
1.2. Role of Nanomaterials in Biosensing
Nanomaterials are nano-sized (1–100 nm) materials with three-dimensional (3D) space [25]. In the
current scenario, the research regarding various nanomaterials is evolving immensely in such a way that
they are successfully becoming an element in our routine lifestyle in terms of food safety, environmental
sciences, cosmetics, therapeutics, drug delivery, biosensors, etc. [26–28]. With these, routes for the
divulgence of nanomaterials to humans and ecological systems are increasing. Such nanomaterials
have been extensively explored in modifying electrode surfaces to fabricate biosensors for their further
improvement with respect to the critical features like reproducibility, selectivity and sensitivity, owing
to their excellent biocompatibility, structural compatibility and strong adsorption capability [29].
They exhibit unique biological and physicochemical characteristics, macroscopic quantum tunneling
effects, surface effects and small size effects. Therefore, they are quite distinct from their conventional
counter-parts as far as their optical, electrical, magnetic, mechanical and catalytic behaviors are
concerned. This makes them suitable for the development of biosensors [30–33]. Additionally, they are
often used for signal amplification by serving as nanocarriers including electron transfer promoters,
nanozymes, detector bioreceptors, electroactive labeling elements, and catalysts [34–37], hence offering
novel strategies for biosensing platforms and their practical applicability. Over the last decade,
numerous nanomaterials have been continuously studied and employed as signal-amplifying species
such as nanoparticles (NPs) [38–40], graphene [41–43], nanowires [44], carbon nanotubes (CNTs) [45],
magnetic beads [46,47] and quantum dots (QDs) [48,49]. Among these nanomaterials, QDs such as
graphene quantum dots (GQDs) and carbon dots (CDs) are becoming quite well-known for their
multifarious properties such as signal amplifying characteristics, good biocompatibility, tunable size,
electro-catalytic performance as well as their capacity for the concurrent and multiple detection
of biomolecules. Moreover, their robustness, inertness, non-toxicity, long-term chemical stability,
water-solubility as well as their photo-stability against both photo-bleaching and blinking are some of
the typical characteristics that are considered for their applications in biomedicine. Nevertheless, they
can be readily functionalized and their synthetic procedures are quite effortless [49–55].
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1.3. Ideal Properties of Graphene Quantum Dots (GQDs)
Being zero-dimensional (0D), GQDs are carbon-based anisotropic nanomaterials constituting a
fabric-like structure homologous to graphene. The morphological features of GQDs imitate both CDs as
well as graphene [56]. They are broadly employed as smart probes for environmental, optoelectronics,
electrochemical and biological operations [49,57–59]. Their edge dimension is bigger than their vertex,
rendering single or manifold panels of graphene with chemical moieties on their lateral surface, which
deliver a large number of sites for chemical functionalization [49]. They can be easily conjugated
with several nanomaterials via pi–pi interaction, with a purpose to generate hybrid nanomaterials [60].
Furthermore, GQDs can also be grafted with antibodies, proteins and small-nucleic acids due to their
dimensional resemblance to such molecules. They can effectively enhance the surface of biosensors for
absorbing a noticeable number of receptors [54,61,62].
Innumerable nanomaterials exhibiting stable and strong fluorescence, including carbon
nanomaterials, up-conversion nanoparticles, metal nanoparticles, polymer-encapsulated organic
nanoparticles, inorganic silica nanoparticles and semiconductor QDs have been reported for their
efficient biosensing applications. Among these, semiconductor QDs were so far preferred as ideal
fluorescent probes owing to their narrow range of emission, broad excitation wavelength, good
photo-stability and easy functionalization ability with surface reagents. Nonetheless, most of the
semiconductor QDs (i.e., PbS, CdTeSe@CdZnS, CdTe@CdSe and CdHgTe) comprise heavy metals,
resulting into unfavorable environmental and biological detrimental effects, which obstruct their
biomedical applicability [63–65]. However, GQDs being a member of the carbon family have emerged
as novel carbon-based fluorescent materials, due to their excellent biocompatibility, fluorescence
property and non-toxicity. These features of GQDs make them ideal nanomaterials for biomedical
applications over other semiconductor nanomaterials.
According to several studies, when the light-emitting attributes of GQDs have been taken into
consideration, their origin is still unclear because their extrinsic states seem to be derived from
undesired impurities and foreign moieties, although their luminescent property primarily originates
from quantum confinement. In close proximity, the influence of oxygen functionalities on the
luminescence of GQDs must be thoroughly investigated to understand its luminescent behavior [66].
Exclusively, GQDs can act as nanozymes or electro-catalysts for catalyzing hydrogen peroxide
(H2O2) to determine target analytes via a label-free approach [67]. They exhibit peroxidase (POD)-like
catalytic features that result in a redox reaction between H2O2 and an electron-donating substrate.
In the sector of biosensors, an enzyme called horseradish peroxidase (HRP) is often associated with the
labeling of secondary bioreceptors for the corresponding analyte determination, which in turn makes
the assays more tedious and costlier [18]. To carry out these procedures faster and cost-effectively,
GQDs are now utilized for replacing HRP-conjugated secondary bioreceptors [53,67,68].
GQDs serve as attractive fluorophores, i.e., as fluorescent labels, quenchers and energy as well as
charge donors [69]. They are fluorescent nanosized graphene segments, which lead to quantum-size
effects and exciton confinement in the range from 3 to 20 nm particles [70,71]. This is considering the
fact that graphene exhibits zero band, produces non-luminescence and possess a ‘Bohr radius’ with an
infinite excitation that exhibit quantum confinement in defined sized particles [72]. Contradictorily,
GQDs possess a band-gap due to their quantum confinement, lateral effects and size-effects that can
be readily altered by virtue of their size and edge chemistry [57,72]. In contrast to semiconductor
QDs, which acquire double quantum states (qs.) at a certain level of energy, GQDs have twice more
(i.e., 4 qs.). These surplus qs. make GQDs suitable for computational quantum analysis [49,60].
1.4. Approaches to Synthesize GQDs for Biomedical Sensors
GQDs can be prepared using a broad range of methods, some of which are elaborated in the
ensuing sections along with their role in the respective biosensor development. Nonetheless, GQDs
with distinguishable and adjustable sizes can be chemically prepared by following one of two strategies:
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(a) In a top-down approach, graphene oxide (GO) or 2D graphene sheets, CNTs, graphite or carbon
fibers are fragmented to obtain 0D GQDs [73–75].
(b) In a bottom-up approach, synthesis of GQDs is usually conducted by a series of chemical reactions
engaging small molecular precursors [58,71].
Since 2015, many investigational studies on GQD biosensors have made a giant step forward due to
their aforementioned characteristics [67,76–78]. These studies could specifically and sensitively detect
target analytes by virtue of multiplexing electrodes such as screen-printed carbon electrodes (SPCE),
screen-printed gold electrodes (SPGE) glassy carbon electrodes (GCE), etc. These sensing platforms
have been validated to perform cost-effective, trustworthy, utterly sensitive and exact detection of target
biomolecules for governing healthcare systems [79]. Moreover, some biosensors have been reported to
offer multiplexed ability for concurrent detection of multiple biomolecules [80,81]. To comprehend the
recent achievements, main features and general working principle behind the GQD biosensors reported
from 2015 onwards, we have discussed them in the ensuing sections; according to the transducer
type, i.e., optical, electrochemical and photoelectrochemical, and sensors for biomedical applications.
The reviewed GQD-sensing techniques and their biomedical applications are outlined in Figure 1.
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2. Optical GQD Sensor in Biomedical Diagno
Optical biosen or are among the well-est li sensors for d termining target biomolecules.
Commonly, they bring together an emitting light source, a odulating element, a bio-receptor and a
photo-detector for interpreting the optical response of a generated signal [11,82]. Optical transducers
include fluorescence, photoluminescence (PL), chemiluminescence (CL), electrochemiluminescence
(ECL), fluorescence resonance energy transfer (FRET) or Förster resonance energy transfer,
interferometry, optical wavelength-modulated spectroscopy and surface plasmon resonance
(SPR) [11,82–87]. These techniques interpret optical signals that are highly sensitive to the refractive
index variation in the proximity of bio-recognition events [86].
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2.1. Fluorescence-Based GQD Sensors
Fluorescence is a process with a short life-span of luminescence generated due to the creation of
electromagnetic excitation upon a material absorbing higher light energy and consecutively, emitting
lower light energy, i.e., at a shorter and longer wavelengths, respectively [88–90]. In fluorescence,
duration from the absorption till emission phenomena is within just a fraction of a second, ranging
from 10−9 to 10−8 s. [91]. When GQDs are employed for biomedical applications, besides excitation
wavelength, ambient pH should also be considered, since it determines the quantum efficiency of
the fluorescence excitation [92]. It is worth mentioning that there have been plenty of GQD sensors
reported in last few years displaying the role of their fluorescent characteristics.
In 2019, Li et al. synthesized pentaethylenehexamine and histidine-functionalized graphene
quantum dots (PEHA-GQD-His) [93]. The as-prepared PEHA-GQD-His served as the fluorescence
probe for a microRNA (miRNA) fluorescence biosensing nanoplatform assembled with a molecular
beacon double-cycle amplification approach. The study involved the specific binding of the target
microRNA to the molecular beacon to provoke the target cycle and the molecular beacon cycle,
generating a DNA nanoassembly on the PEHA-GQD-His film. The terminated G-quadruplexes
could fold and fuse to hemin well enough to establish hemin/G-quadruplex complexes. Thereafter,
the fluorescence emission intensity of PEHA-GQD-His could be quenched through photoinduced
electron transfer by an electron acceptor and hemin anchored on the PEHA-GQD-His, which
resulted in an in situ development by the H2O2 decomposition, because of the G-quadruplex/hemin
DNAzymes’ catalytic performance. This approach indicates that the design of a target and beacon
double cycle can promote specific DNA nanoassembly on the PEHA-GQD-His surface, whereas the
DNAzyme-attenuated double-quenching mechanism can attain fluorescence-quenching ability of
PEHA-GQD-His. Moreover, the presence of PEHA elevates the fluorescence emission intensity of
PEHA-GQD-His, where histidine increases the catalysis of G-quadruplex/hemin DNAzymes towards
H2O2. This biosensor could deliver a sensitive fluorescence response towards miRNA in human serum
in a linear calibration range of 1 × 10−18–1 × 10−12 M and could achieve 4.3 × 10−19 M as the limit of
detection (LOD).
In 2016, Laurenti et al. reported a biosensor using single stranded DNA (ssDNA) and GQDs,
which were coupled with the up-conversion nanoparticles (UCNPs) and silica (SiO2) for determining
miRNA sequences [94]. The sensor involved the interaction of sp2 carbon atoms of the GQDs with
ssDNA-UCNPs through pi–pi stacking, which could bring GQDs to the ssDNA-UCNP/SiO2 surface.
This led to an increase in the up-conversion emission and at the same time, hybridization of the ssDNA
with their correspondent complementary miRNA sequences hindered UCNPs to react with the GQDs
via pi–pi interaction. This resulted in a diminished fluorescence emission intensity depending on the
concentration of miRNA sequences. This strategy for developing a sensing platform for miRNA
sequences could achieve an LOD of 10 fM.
Since DNA methyltransferase (M.SssI) enzyme plays a significant role in several biological
processes and its abnormal expression can cause cancer, Kermani and the team introduced a biosensing
method for monitoring the activity of this enzyme in human serum [95]. This method was based
on DNA-functionalized GQDs for a fluorescence-based assay as shown in Figure 2. An aminated
double stranded-DNA (ds-DNA) was formed that constituted a recognition site for M.SssI as well as
endonuclease HpaII. Upon the fusion of ds-DNA to GQDs, a significant reduction in fluorescence
intensity of about 45% was observed, while ds-DNA was methylated upon the conjugation with M.SssI,
leading to develop resistant to cleavage by HpaII and no change in fluorescence. On the other hand,
in the absence of M.SssI enzyme, HpaII could easily cleave ds-DNA and resulted in an increased
fluorescence. This method could detect M.SssI with an LOD of 0.7 U mL−1. Moreover, fluorescence
anisotropy was also conducted for confirming the DNA modification and liberation of ds-DNA from
the GQDs’ surface in the existence of M.SssI and HpaII, respectively.
Sensors 2020, 20, 1072 6 of 71
Sensors 2020, 20, x FOR PEER REVIEW 6 of 70 
 
 
Figure 2. Schematic representation of a fluorescent assay for DNA methyltransferase activity [95]. 
A label-free GQD-based ratiometric fluorescence assay was proposed for detecting the DNA by 
merging the cutting endonuclease enzyme supported with the hemin DNAzyme/ G-quadruplex bio-
catalysis via the target recycling as well as a cascade signal amplification strategy [96]. In the study, 
o-phenylenediamine (OPD) was chosen as a hemin DNAzyme/G-quadruplex substrate, where 2,3-
diaminophenazine (DAP), i.e., the oxidized product, could quench the fluorescence of GQDs (~460 
nm), coupled with a fresh emission of DAP (~564 nm). Such a ratiometric signal (i.e., I564/I460) could 
sensitively and specifically determine target DNA, with an LOD of 30 fM. 
In 2017, Sun and co-workers constructed a biosensor for determining cholesterol using 
hydrothermally synthesized nitrogen-doped GQDs (N‒GQDs) having quantum yield (QY) of 80%. 
These N‒GQDs were coupled with chromium picolinate (CrPic), where the researchers explored the 
fluorescence-quenching effect of the CrPic/N‒GQDs complex. [97]. The research involved the 
implantation of CrPic on to the N‒GQDs through a cross-linking agent, cysteamine (Cys) as well as 
the quenching of the N‒GQDs’ fluorescence intensity. This was achieved via a phenomenon called 
‘photoinduced electron transfer’ (PET), where CrPic and N‒GQDs acted as the electron-donating and 
electron-accepting groups, respectively. Subsequently, cholesterol was introduced to form a 
CrPic/N‒GQDs complex, since CrPic could serve as an efficient cholesterol-receptor as well, through 
affinity binding as well as π–π stacking. A significant enhancement in fluorescence emission intensity 
of CrPic/N‒GQDs implied the ability of cholesterol to enhance the conductivity of N‒GQDs. The 
authors stated that this CrPic/N‒GQDs-based biosensor could clinically detect cholesterol in human 
serum, where the linear concentration range and LOD were observed to be 0–520 mM and  
0.4 mM, respectively. 
Using europium (Eu)-macromolecule complex, Ryu et al. functionalized GQDs with two different 
sizes that were employed for developing a fluorescent sensor for Bacillus anthracis spores [98]. This 
GQDs‒Eu dual emission biosensor possessed high sensitivity, morphology of ultrafine particles, 
improved dispersibility and enhanced surface-to-volume ratio. The GQDs‒Eu displayed multiple 
emission bands, which could be attributed to the fluorescence emitted from the red dipicolinic acid–Eu 
(DPA–Eu) complex (i.e., ~593 nm and ~616 nm) as well as from the blue GQDs (~435 nm). As a 
consequence, GQDs were introduced as a non-interfering internal calibration to form a ratiometric 
sensor. The time-dependent fluorescence relationship confirmed the completion of a reaction, which 
facilitated the rapid detection of B. anthracis spores within 8 s. The as-prepared Eu‒GQDs sensor could 
demonstrate the quantification of B. anthracis with an LOD of around 10 pM, which was 6-fold less than 
the infectious dose of B. anthracis spores. Moreover, the cross-reactivity study revealed that GQDs‒Eu 
sensors could show selectivity of about 103 times for DPA in comparison to the competing  
aromatic ligands. 
Figure 2. Schematic representation of a fluorescent assay for DNA methyltransferase activity [95].
A label-free GQD-based ratiometric fluorescence assay was proposed for detecting the DNA
by merging the cutting endonuclease enzyme supported with the hemin DNAzyme/G-quadruplex
bio-catalysis via the target recycling as well as a cascade signal amplification strategy [96]. In the
study, o-phenylenediamine (OPD) was chosen as a hemin DNAzyme/G-quadruplex substrate, where
2,3-diaminophenazine (DAP), i.e., the oxidized product, could quench the fluorescence of GQDs
(~460 nm), coupled with a fresh emission of DAP (~564 nm). Such a ratiometric signal (i.e., I564/I460)
could sensitively and specifically determine target DNA, with an LOD of 30 fM.
In 2017, Sun and co-workers constructed a biosensor for determining cholesterol using
hydrothermally synthesized nitrogen-doped GQDs (N-GQDs) having quantum yield (QY) of 80%.
These N-GQDs were coupled with chromium picolinate (CrPic), where the researchers explored
the fluorescence-quenching effect of the CrPic/N-GQDs complex. [97]. The research involved the
implantation of CrPic on to the N-GQDs through a cross-linking agent, cysteamine (Cys) as well as
the quenching of the N-GQDs’ fluorescence intensity. This was achieved via a phenomenon called
‘photoinduced electron transfer’ (PET), where CrPic and N-GQDs acted as the electron-donating
and electron-accepting groups, respectively. Subsequently, cholesterol was introduced to form a
CrPic/N-GQDs complex, since CrPic could serve as an efficient cholesterol-receptor as well, through
affinity binding as well as pi–pi stacking. A significant enhancement in fluorescence emission intensity of
CrPic/N-GQDs implied the ability of cholesterol to enhance the conductivity of N-GQDs. The authors
stated that this CrPic/N-GQDs-based biosensor could clinically detect cholesterol in human serum,
where the linear concentration range and LOD were observed to be 0–520 mM and 0.4 mM, respectively.
Using europium (Eu)-macromolecule complex, Ryu et al. functionalized GQDs with two
different sizes that were employed for developing a fluorescent sensor for Bacillus anthracis spores [98].
This GQDs-Eu dual emission biosensor possessed high sensitivity, morphology of ultrafine particles,
improved dispersibility and enhanced surface-to-volume ratio. The GQDs-Eu displayed multiple
emission bands, which could be attributed to the fluorescence emitted from the red dipicolinic acid–Eu
(DPA–Eu) complex (i.e., ~593 nm and ~616 nm) as well as from the blue GQDs (~435 nm). As a
consequence, GQDs were introduced as a non-interfering internal calibration to form a ratiometric
sensor. The time-dependent fluorescence relationship confirmed the completion of a reaction, which
facilitated the rapid detection of B. anthracis spores within 8 s. The as-prepared Eu-GQDs sensor
could demonstrate the quantification of B. anthracis with an LOD of around 10 pM, which was 6-fold
less than the infectious dose of B. anthracis spores. Moreover, the cross-reactivity study revealed that
GQDs-Eu sensors could show selectivity of about 103 times for DPA in comparison to the competing
aromatic ligands.
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Ascorbic acid (AA) is a vitamin, which has a pivotal function in several physiological reactions
occurring in living cells and abnormal levels can cause various diseases. Thus, it is crucial to develop
potent methods than can accurately determine the AA level in human cells. In 2017, Feng and the team
found that the near-infrared (NIR)-GQDs could produce a two-photon (TP) excitation with cross-section
(δΦ) of 25.12 Goeppert–Mayer units and generated an NIR peak (~660 nm) upon excitation with
810 nm fs pulses [99]. Having exhibited TP fluorescence characteristics, these NIR-GQDs were used
to fabricate a TP nanoprobe for detecting endogenous AA in the human body. Herein, NIR-GQDs
that act as fluorescence reporters, possessed lower fluorescence background that could sharpen the
fluorescence-imaging resolution. Moreover, cobalt oxyhydroxide (CoOOH) nanoflakes served as
fluorescence quenchers by fusing with the NIR-GQDs surface. In the presence of AA, CoOOH
was converted to Co2+ via a reduction reaction, which generated a “turn-on” fluorescence signal of
NIR-GQDs. This nanosystem could susceptibly detect AA with an LOD of 270 nM.
Another biosensor based on the fluorescence turn-on assay approach for determining AA
concentrations in human serum was also reported in 2017 [100]. In this study, the researchers
investigated the orange emission of GQDs and the role of HRP as well as H2O2. Injection of HRP and
H2O2 oxidized catechol resulted in the conversion of o-benzoquinone that could effectively quench
the fluorescence of GQDs. Nonetheless, when AA was introduced, H2O2 and hydroxyl radicals were
consumed that led to the inhibition of o-benzoquinone production, resulting in fluorescence recovery.
Fluorescence emission intensity gave a linear correlation for H2O2 concentrations from 3.33 to 500 µM,
while that with the AA concentrations from 1.11 to 300 µM. The detection limits for H2O2 and AA
were observed to be 1.2 µM and 0.32 µM, respectively.
In 2018, Na et al. established a detection strategy for AA as well as alkaline phosphatase (ALP)
enzyme, where a fluorescence “turn off-on” assay was designed through the in situ formation of MnO2
nanosheets with sulfanilic acid functionalized GQDs (Sa-GQDs) [101]. In the study, ALP could catalyze
the hydrolysis of amifostine to S-2-(3-aminopropylamino)-ethanethiol (molecule A), and the addition of
KMnO4-produced MnO2 nanosheets and molecule B (i.e., the polyamine disulfide form of molecule A).
Subsequently, the energy transfer platform was constructed by adhering Sa-GQDs to MnO2 nanosheets
through molecule B as a crosslinking reagent, which resulted in the fluorescence quenching of Sa-GQDs
by MnO2 nanosheets. AA led to the decomposition of MnO2 into Mn2+ owing to its extraordinary
reducing ability and disintegrated the MnO2 nanosheets that could liberate Sa-GQDs, thereby recovering
the quenched fluorescence. Additionally, both the ALP as well as AA generated the change in color
of solution due to the redox reaction of MnO2 nanosheets. Therefore, MnO2 nanosheets could also be
employed as colorimetric probes for the quantification of ALP and AA via direct visualization through
the naked eye. This Sa-GQDs/KMnO4/amifostine/ALP system provided a linearity, ranging from 0.5 to
20 µmol L−1 AA concentration, with the quantification limit of 0.16 µmol L−1.
On the basis of a chemical redox strategy for modulating the fluorescence of N-GQDs, a biosensor
for tracing the ALP concentration has been proposed [102]. Initially, the fluorescence of N-GQDs was
effectively quenched by ultrathin CoOOH nanosheets, followed by the restoration through AA that
could convert CoOOH to Co2+ by reduction reaction. Hence, the ALP activity was sensed, depending
on the hydrolytic performance of ALP for converting L-ascorbic acid-2-phosphate (AAP) to AA by
ALP. This label-free biosensor could quantify the ALP concentration, ranging from 0.1 to 5 U L−1 with
an LOD of 0.07 U L−1. Another label-free biosensing platform for ALP activity determination was
reported, where GQDs with high QY were synthesized by a single-step reaction [103]. In the study,
two linear calibration plots were observed, ranging from 0.05 to 2.5 nM and 5 to 10 nM, respectively.
The optimized values implicated that this nanoprobe could detect ALP with an LOD of 0.017 nM.
In 2019, Cui et al. introduced a concept of a ‘turn-on’ magnetic fluorescent biosensor (Figure 3)
using molybdenum disulfide (MoS2) nanosheets, Fe3O4 and GQDs for detecting circulating tumor cells
(CTCs) [104]. In this approach, electrochemically synthesized GQDs were modified with a magnetic
agent and EpCAM (epithelial cell adhesion molecule) aptamer. MoS2 nanosheets act as a fluorescence
quencher, which was coupled with the GQD/Fe3O4/EpCAM aptamer complex. This fusion led to the
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formation of ‘turn-on’ biosensing magnetic fluorescent nanocomposites (MFNs). These MFNs render
a negligible cellular toxicity with around 90% of an average capture efficacy (i.e., higher than that
of other magnetic NPs). Moreover, the MFNs-based biosensor could rapidly sense and label CTCs
within 15 min, beating several other steps of detection techniques. In the presence of EpCAM aptamers,
the MFNs are specific for capturing CTCs (i.e., both low- and high-EpCAM-expressing cells). It was
reported that this strategy could detect up to 10 tumor cells in human blood with a linear detection
range and detection limit of 2–64 nM and 1.19 nM, respectively.
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Dopamine (DA), the catecholamine neurotransmitter has a pivotal function in regulating hormones
as well as in metabolizing cells. Moreover, it acts as a biomarker in diseases related to its secretion,
which include Parkinson’s disease, Huntington’s disease, schizophrenia, senile dementia, anorexia
etc. [105,106] Therefore, it is essential to monitor DA levels for which numerous GQD sensors based on
fluorescence have already been reported.
Zhou and co-workers constructed an MIP-based sensor for mapping DA using polyindole (PIn)
and GQDs [107]. The PIn/GQDs@MIPs sensing system could readily bind DA and showed a high
sensitivity for DA concentrations with a wide linear array from 5 × 10−10 to 1.2 × 10−6 M and an LOD of
1 × 10−10 M, owing to the t ilor-made imprinted cavities via hydrogen bonds betwee O2-rich groups
of the nanocomposite and amine groups of DA. Additionally, this sensor could rebind DA in dual-type:
a high-affinity type and a low-affinity type (i.e., when non-covalent interaction is “on” and “off”,
respectively), where the rebinding step could be controlled through pH modulation, suggesting distinct
binding efficiency for tuning the binding interaction. This research group had also demonstrated
a fluorescent sensing strategy for DA determination with the use of polypyrrole (PPy) and GQDs
core/shell hybrids [108]. These nanocomposites delivered a strong fluorescence emission, which was
3 orders of magnitudes higher than that by pristine GQDs. This sensor could result in a fluorescent
emission intensity falling off with the increasing DA conce trations in the range of 5 to 8000 nM.
Moreover, the quantification limit for DA was dow to 10 pM. Later on, in 2017, the same roup used
MIP/GQDs and poly(indolylboronic acid) (PIn-BAc) for the identific tion of DA [105]. While preparing
the MIPs@PIn-BAc/GQDs system, the introduction of DA led to the fluorescence quenching of the
nanocomposites as well as agglomeration due to the covalent interaction between boronic acid and
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catechol group of DA. The results revealed that this system could also provide a wide linear range
of DA concentration, ranging from 5.0 nM to 1.2 µM and the detection limit of 2.5 nM. Moreover,
it was reported that all these three sensors could perform well against several interfering biomolecules.
Hence, they can exhibit high specificity and can be employed for the clinical testing of DA in human
biological media.
In 2016, Zhao et al. fabricated a label-free technique, taking GQDs as effective probes for the
quantification of DA [109]. GQDs gave a strong blue fluorescence in aqueous solution, which was then
quenched by adding DA. The quenching mechanism was based on the transfer of electrons from the
photo-excited GQDs to DA–quinine that was generated through DA oxidization by O2 in alkaline
environment. The quenched fluorescence was directly co-related with the DA concentration in the
range of 0.25 to 50 µM, with an LOD of 0.09 µM. In the same year, Tashkhourian and Dehbozorgi
synthesized GQDs via control carbonization of citric acid for testing DA levels in human serum [110].
Herein, DA could quench the fluorescence emission intensity of GQDs through dynamic quenching.
This technique attained a calibration plot for DA in a linear array of 0.01–50.0 µM, achieving the low
quantification limit of 8.2 nM and exhibited high specificity for DA in the co-existence of interfering
compounds like uric and ascorbic acid.
Xiaoyan et al. studied the role of GO-GQDs and N,S-GQDs in performing HRP modification to
determine H2O2 in real water samples [111]. These GQDs were produced by dissecting GO as well as
by pyrolyzing citric acid and L-cysteine, which revealed an antagonistic influence on the HRP activity.
However, the GO-GQDs-functionalized HRP exhibited an excellent thermo-stability and improved
activity (i.e., 1.9 order of magnitudes higher than pristine enzyme), which can be attributed to the
bigger conjugate rigid plane and lesser hydrophilic groups delivered by GO-GQDs in contrast to the
N,S-GQDs. Such features of GO-GQDs can make them suitable for offering a desired conformational
change in HRP for catalysis, enhanced thermo-stability as well as enzymatic performance. The HRP
functionalized by GO-GQDs was also used for bio-catalysis to probe H2O2 by a fluorescence biosensor.
It was observed that transparent tetramethylbenzidine (TMB) was oxidized into blue-colored TMB in
the co-existence of H2O2 by support of HRP functionalized with GO-GQDs, resulting in the quenching
of GO-GQDs’ fluorescence. The fluorescence emission intensity was decreased in a linear fashion
with increasing concentration of H2O2, ranging from 2 nM to 200 µM and an LOD value of 0.68 nM
was achieved.
The nanoprobe development for TP microscopy is in huge demand to screen various biomolecules
in humans, but these nanoprobes are limited to single-color fluorescence variations, which make
them inappropriate for quantitative analysis. To overcome these limitations, a rational dual-emission
and TP-GQDs probe for sensing H2O2 has been reported [112]. Herein, a boronate ester-modified
merocyanine (BMC) fluorophore was employed as target-activator and as a dual-emission fluorescence
modulator to specifically recognize H2O2 and to quench the fluorescence of TP-GQD. Upon TP
excitation (~740 nm), TP-GQD−BMC revealed a green-to-blue colored fluorescence corresponding to
H2O2 with a shift in emission (~110 nm), and the H2O2 could be successfully probed in the range of
0.2–40 µM, with a detection limit of 0.05 µM.
In 2018, Qu et al. designed a biosensor for mapping phytic acid (PA) and H2O2 exploiting the role
of glutathione (GSH)-modified GQDs [113]. The fluorescence of GQDs@GSH was quenched by Fe3+
ions through a PET process. When the PA was introduced to GQDs@GSH/Fe3+ system, the fluorescence
of GQDs@GSH was considerably recovered by the assistance of the strong reducing and chelating
efficiency of PA, where Fe3+ ions were reduced to Fe2+ ions by PA and led to the development of a
PA/Fe2+ complex. Such an ‘off–on’ fluorescence strategy was proposed for determining PA owing to
the use of GQDs@GSH/Fe3+ as a fluorescent probe. Moreover, the same strategy could also detect
H2O2, where H2O2 could inactivate the chelate structure of PA/Fe2+, liberate Fe2+ ions and oxidize
Fe2+ ions to generate Fe3+ ions, resulting in the fluorescence quenching of GQDs@GSH. This approach
could serve a broad linear response for both PA and H2O2 in the range of 0.05 to 3 µmol L−1 and 0.5 to
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10 µmol L−1, respectively. The estimated LOD values of PA and H2O2 were reported to be 14 nmol L−1
and 0.134 µmol L−1, respectively.
A GQD-biosensor based on the synergetic effect of enzyme-coupled technique and fluorescence
quenching was engineered for monitoring glucose levels in human serum samples [114]. As explained
in Figure 4, oxidation of glucose was achieved by the glucose oxidase (GOx) enzyme, producing H2O2.
Subsequently, H2O2 could oxidize phenol to quinone in the presence of HRP for potential quenching of
the GQDs–GOx–HRP–phenol system. Such a sensing system could effectively determine blood glucose
levels with a linear relationship between the glucose concentration and the fluorescence intensity,
ranging from 0.2–10 µmol L−1 and an achievement of 0.08 µmol L−1 as the detection limit. Another
glucose sensor employing the GOx enzyme and GQDs was developed, where the researchers used
hemin-functionalized GQDs [115]. The GQDs were synthesized through the pyrolysis of citric acid,
which were highly water-soluble and highly fluorescent. Because of non-covalent binding between
hemin and GQDs, hemin could help H2O2 to demolish the GQD-surface that quenched the fluorescence
emission intensity of GQDs. The results displayed a wide linear range of glucose from 9 to 300 µM,
with an LOD of 0.1 µM.
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Table 1. Metal ion detection using fluorescence based GQD sensors for biomedical applications.
Nanomaterials Target Metal Ion Linear Range LOD Reference
GQDs Cu2+ 0–15 µM 0.226 µM [116]
r–GQDs/GO Pb2+ 1–400 nM 0.6 nM [117]
GQDs@AuNPs Pb2+ 50 nM–4 µM 16.7 nM [118]
N,S–GQDs Hg2+ 0.1–15 µM 0.14 nM [119]
Val–GQDs Hg2+ 0.8 nM–1 µM 0.4 nM [120]
S–GQDs Ag+ 0.1–130 µM 30 nM [121]
GQDs@OPD Ag+ 0–115.2 µM 250 nM [122]
GQDs@AgNPs Ag+ 0–100 nM 3.5 nM [123]
Cit-UCNPs/GQDs Ag+ 2 × 10−4–1 µM 60 pM [124]
N–GQDs Fe3+ 1–1945 µM 90 nM [125]
RBD–GQDs Fe3+ 0–1 µM 0.02 nM [126]
N–GQDs Fe3+ 1–500 µM 1 µM [127]
B–GQDs Fe3+ 50 nM–420 µM 31.2 nM [128]
DA–GQDs Fe3+ 20 nM–2 µM 7.6 nM [129]
S–GQDs Fe3+ 0.01–0.70 µM 4.2 nM [130]
Abbreviations: Ag+: Silver ion; B–GQDs: Boron doped GQDs; Cit-UCNPs: Sodium citrate functionalized up
conversion nanoparticles; Cu2+: Copper (II) ion; DA–GQDs: Dopamine-functionalized GQDs; Fe3+: Ferric (III)
ion; GO: Graphene oxide; GQDs: Graphene quantum dots; Hg2+: Mercury (II) ion; N–GQDs: Nitrogen-doped
GQDs; N,S–GQDs: Nitrogen and sulfur-doped GQDs; OPD: o-phenylene diamine; Pb2+: Lead (II) ion; RBD–GQDs:
Rhodamine-functionalized GQDs; r–GQDs: reduced GQDs; N–GQDs: Nitrogen-doped GQDs; Pb2+: Lead (II) ion;
Val–GQDs: Valine-functionalized GQDs.
Apart from the aforementioned GQD sensors, numerous other sensors based on fluorescence have
also been reported recently for a wide range of biomedical applications. For instance, efficient cancer
diagnosis can be achieved through the development of GQD-biosensors by detecting biothiols (e.g., GSH,
cysteine or homocysteine) in human serum [131]; an “ON-OFF” biosensor employing GQDs and gold
nanocrosses (AuNCs) for tracking intracellular adenosine triphosphate (ATP) concentrations [132];
N–GQDs with a vanadium pentoxide (V2O5) nanosheet-implanted sensing platform for cysteine [133];
a N–GQD/silica based MIP-sensor for cytochrome-C (Cyt-C) [134]; a selenium-implanted GQD-sensor
for the simultaneous determination of oxidative hydroxyl radical (•OH) and reductive GSH in HeLa
cells [135]; as well as for mapping various enzymes such as trypsin and tyrosinase using a Cyt-C
induced GQD-sensor [136]; and an N–GQDs decorated biosensor [137], respectively. A sensor coupled
with tyramine-functionalized GQDs has been reported to screen metabolites (i.e., glucose, cholesterol,
L-lactate, xanthine) for monitoring several metabolic disorders like diabetes, obesity, lactic acidosis, gout
and hypertension [138]. Also, pharmaceutical agents like tacrine (a cholinesterase inhibitor for treating
patients with neurodegenerative disorders) and triclosan (an antibacterial drug) can be quantified
by virtue of biosensors involving the role of N–GQDs/acetylcholinesterase (achE) enzyme [139] and
silicon–GQDs assembled with ruthenium (III) ions [140], respectively. Fluorescence-based GQD-sensors
could also quantify pathogens like tuberculosis causing CFP-10 (culture filtrate protein) [141] and water
pollutants like trinitrophenol (TNP) [142]. Furthermore, the critical features of some GQD-sensors
based on the employed receptor-type are listed in Table 2.
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Table 2. Various GQD sensors based on fluorescence for biomedical applications developed over the last five years.
Nanomaterials Receptor Type Receptor Target Analyte Linear Range Detection Limit Sample(s) Reference
GQDs Nucleic acid G-quadruplex/heminDNAzyme Uric acid 2–300 µM 500 nM Human serum; Urine [143]
N–GQDs MIP PDA-imprintedpolymer Thiacloprid 0.1–10 mg L
−1 0.3 mg L−1 Vegetables [144]
GQDs Enzyme HRP
o-DHB;
m-DHB;
p-DHB
0.5–250 nM;
1–120 nM;
0.5–90 nM
2 × 10−10 mol L−1;
8 × 10−10 mol L−1;
3 × 10−10 mol L−1
Rain water; tap water [145]
GQDs/MoS2
nanosheets Nucleic acid Aptamer EpCAM 3–54 nM 450 pM Human serum [146]
GQDs MIP Atropine-imprintedpolymer Atropine 0.5–300 × 10−9 g mL−1 0.22 × 10−9 g mL−1 Urine; Human blood [147]
GQDs/Fe3O4 Antibody Anti-IgG IgG 2.0–2.0 × 103 casts mL−1 2.0 casts mL−1 Urine [148]
N–GQDs Nucleic acid ss-DNA Bleomycin 0.34–1300 nmol L−1 0.34 nmol L−1 Human serum [149]
GQDs Enzyme Urease Urea 0.1–100 mM 0.01 mM Human blood [150]
GQDs MIP tetracycline-imprintedpolymer tetracycline 1–10
4 µg L−1 1 µg L−1 Milk [151]
NH2–GQDs Nucleic acid
G-quadruplex/hemin
DNAzyme
Human telomere
DNA 0.2–50 pM 25 fM Buffer; Human blood [152]
Silica–GQDs MIP 4-NP imprintedpolymer 4-NP 0.02–3 µg mL
−1 9 ng mL−1 water [153]
GQDs/p-ABA Enzyme Tyrosinase Artemisinin 0.1–55 µM 33 nM Pharmaceuticals [154]
GQDs MIP Silica-MIP Ornidazole 0.75–30 µM 0.24 µM Human plasma [155]
Abbreviations: 4-NP: Para-nitrophenol; DNA: Deoxyribonucleic acid; DHB: Dihydroxybenzene; EpCAM: Epithelial cell adhesion molecule; Fe3O4: Ferric ferrous oxide; GQDs: Graphene
quantum dots; HRP: Horse-radish peroxidase; IgG: Immunoglobin-G; MIP: Molecularly imprinted polymer; MoS2: Molybdenum disulfide; N–GQDs: Nitrogen-doped GQDs; p-ABA:
p-amino benzoic acid; PDA: Polydopamine; ss-DNA: Single-stranded DNA.
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2.2. Photoluminescence-Based GQD-Sensors
Photoluminescence (PL) is also a phenomenon involving light emission from fluorophores or
fluorochromes like GQDs after the absorption of photons (i.e., electromagnetic radiation). It is one of
the types of luminescence, which is promoted by photoexcitation. In other words, it is a process of
photons that excite electrons to a higher energy level in an atom [89,90]. The working principle behind
PL sensors resembles that of fluorescence-based sensors. Although PL and fluorescence are similar
to each other, we categorize these sensors separately according to the terminologies reported in the
respective research works.
In 2018, Sahub et al. designed an enzyme-based sensor for the detection of a pesticide, dichlorvos
(i.e., an organophosphate) as represented in Figure 5A [156]. This strategy involved the production of
H2O2 from the enzymatic reaction of acetylcholinesterase (AChE) and choline oxidase (CHOx), which
could react with GQDs to generate a “turn-off” photoluminescence of GQDs and could be restored at
467 nm in the presence of dichlorvos. The change in PL intensity of the GQDs/AChE/CHOx system was
directly proportional to the concentration of dichlorvos and could detect a lower amount of dichlorvos
down to 0.172 ppm (~0.778 µM). Such a facile and cost-effective biosensor was developed to interrogate
the presence of organophosphate pesticides in food, water and the environment. Another GQD-sensor
for the determination of pesticides was constructed by Zor et al. As shown in Figure 5B [157].
Herein, a multifunctional nanocomposite, i.e., magnetic silica beads/GQDs/molecularly imprinted
polypyrrole (mSGP), was synthesized for specifically capturing and signaling small molecules owing
to the synergism offered by this composite in terms of optical, chemical and magnetic features along
with molecular imprinting of tributyltin, a genotoxic substance that can cause endocrine disruptions.
Moreover, its magnetic property could be employed for capturing and pre-concentrating tributyltin on
the surface, and the PL intensity of GQDs was effectively quenched during the binding of tributyltin.
This sensing technique could quantify tributyltin in water and seawater without pretreating the
samples and achieved the LOD values of 12.78 and 42.56 ppb, respectively.
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dichlorvos [156]; (B) MIP-based PL sensor for tributyltin [157].
Zhao et al. investigated a signaling transduction approach based on PL to screen immunoglobulin
G (IgG) via the interaction between graphene (Gr) and GQDs [158]. To engineer the immunosensor,
mouse IgG (mIgG) antibody–GQDs and Gr were selected as donors and acceptors, respectively. On
introducing Gr to the mIgG–GQDs solution, the non-specific binding interaction between the Gr
surface and mIgG as well as the pi–pi stacking between GQDs and Gr could easily bring Gr and GQDs
together in luminescence resonance energy transfer (LRET) to promote the luminescence quenching of
GQDs depending on LRET. The detection step involved the specific binding of human IgG to mIgG
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with the assistance of an immunoreaction that led to the Gr surface being far away from mIgG–GQDs,
which restricted the LRET and recovered the luminescence of GQDs. The increase in PL intensity
was directly correlated with the human IgG concentration, ranging from 0.2 to 12 µg mL−1, with an
estimated LOD of 10 ng mL−1.
In 2018, by using N,S-GQDs, Mondal and team provided a biosensing strategy to measure
the concentrations of nitroexplosive, 2,4,6-trinitrophenol (TNP) [159]. These GQDs could generate
abundant localized energy levels near the conduction band. Only a 90 µM solution of TNP could result
in a considerable improvement in fluorescence quenching of N,S-GQDs (~92%), as compared to their
individual doped states (i.e., either by using N-GQDs or S-GQDs). This could be attributed to the charge
transfer among these doped states to selectively determine TNP. The detection limit was reported to be
19.05 ppb. He et al. demonstrated a facile PL method for the identification of hydroquinone (H2Q),
exploiting the use of GQDs that act as peroxidase-mimicking catalyst as well as PL indicator [160].
When the dissolved oxygen was present, GQDs could oxidize H2Q to p-benzoquinone that could
quench PL of GQDs. This nanosensing PL platform for H2Q provided an LOD of 5 nM.
A facile mix-and-detect PL technique was introduced for the turn-on mapping of acidic amino
acids like glutamic acid (Glu) and aspartic acid (Asp) [161]. Prior to the detection strategy, GQDs that
emit both up-conversion and down-conversion PL intensities were synthesized using the solvothermal
method. The carboxylic acid-rich surface enhanced the water solubility of the GQDs as well as being
able to trigger Eu3+-GQDs aggregation, which led to the effective PL quenching of GQDs. The quenched
PL was restored by competing acidic amino acids with GQDs for Eu3+. The sensitive and specific
analysis of acidic amino acids was reported on the basis of both the up- and down-conversion PL and
it was clearly proved from this research that up-conversion mode delivers a little lower LOD than the
down-conversion process. The detection of Glu was accomplished by up-conversion PL of GQDs,
where the PL intensity steeply increased with the Glu concentrations from 1 to 200 µM, with an LOD
of 0.19 µM. On the other hand, the down-conversion mode for Glu could also follow the same linear
detection range, but with an LOD of 0.32 M. This can be assigned to the greater interference from the
background in down-conversion mode. Under the similar conditions, nearly identical results were
observed for Asp, i.e., a linear detection range from 1 to 220 µM, with LOD values of 0.18 µM and
0.33 µM for up-conversion and down-conversion modes, respectively.
Figure 6 embodies a PL assay for monitoring the protein kinase activity depending on the
selective agglomeration of a phosphorylated peptide−GQD complex triggered by Zr4+ ions [162].
This bioassay showed a decrease in the PL intensity of peptide−GQD complex for casein kinase II (CK2)
concentrations, ranging from 0.1 to 1.0 unit mL−1, with an LOD of 0.03 unit mL−1. Moreover, the EC50
value (i.e., defined as the concentration at which 50% of an enzyme can be converted to substrate) for
CK2 was calculated as 0.34 unit mL−1. The as-developed assay can be applied for the effective screening
of kinase inhibitor within 5 min. To validate the ability of this GQD-based sensor for monitoring the
kinase inhibition activity in complex biological matrices like human serum, the inhibitory activity of
CK2 phosphorylation was demonstrated by various inhibitors such as ellagic acid, emodin, quercetin
and 5,6-dichlorobenzimidazole-l-β-d-ribofuranoside. The results obtained suggested that the PL
intensity increases with increasing inhibitor efficiency in the presence of the aforementioned inhibitors.
For example, the IC50 (i.e., inhibitor concentration resulting in 50% inhibition) in case of ellagic acid
was found as 0.041 × 10−6 M, implying that this assay can be a promising approach to quantify the
enzymes as well as their inhibitors with satisfactory results.
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Ju et al. used hydrothermally prepared N-GQDs having QY of 32.4% (at 350 nm) by following a
one-step reaction of dicyandiamide and citric acid for determining GSH levels in HeLa cells. [163].
The quenching of the PL intensity of bright luminescent N-GQDs could be successfully achieved by
Hg2+ because of the electron transfer as well as the strong electrostatic interaction between N-GQDs
and Hg2+ ions, which was then restored by adding GSH due to the selected combination of GSH and
Hg2+ ions via an Hg2+-S bond. This turn-on fluorescence sensor provided magnificent selectivity
and sensitivity for GSH, and an LOD of 87 × 10−9 M. Safardoust-Hojaghan et al. also carried out
hydrothermal synthesis of GQDs with 25% QY, but using citric acid and ethylenediamine for quantifying
bacterial pathogens such as Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). The authors
confirmed the linear relationship between fluorescence intensity of GQDs and concentrations of both S.
aureus as well as E. coli up to 9 × 107 cfu mL−1 [164].
Zhang et al. prepared boron-doped GQDs (B-GQDs) from boron-doped graphene [165].
The presence of boronic acid groups on the surface of B-GQDs could generate PL for label-free
glucose detection. The study revealed that the reaction between two boronic acid groups on B-GQDs
surfaces and two cis-diol units of glucose facilitate conformationally rigid B-GQDs/glucose agglomerates.
This constrains the intramolecular rotation, thereafter leading to an enhanced PL intensity. Moreover,
the results proved that B-GQDs could be highly specific only to glucose rather than its isomeric cousins
like fructose, mannose and galactose due to their ability to avoid saccharides with only one cis-diol
unit. The PL intensity of this sensor was boosted with elevated glucose concentrations, suggesting a
good sensing performance with a linear range from 0. 05 to 10 mM and an LOD of 0.03 mM. The same
group had developed a GQD-sensor for determining not only glucose but also H2O2 [166]. Herein,
the production of multifunctional and non-covalent hybrids was achieved through pi–pi stacking and
electrostatic interactions between GQDs and Fe3+ 5,10,15,20-tetrakis(1-methyl-4-pyridyl)porphine
(FeTMPyP). The PL of GQDs was quenched by the inner filter effect (IFE) of FeTMPyP on the GQDs.
The quenched PL of GQDs can then be switched back “on” according to the reaction occurring between
FeTMPyP and H2O2 that created rupture of the cyclic tetrapyrrolic nucleus. Subsequently, Fe3+ ions
from FeTMPyP were lost and generated colorless mono- and dipyrroles. This “turn-on” sensing system
could offer a linear calibration plot for glucose and H2O2 concentrations from 3 to 100 µM and 2 to
300 µM, respectively, with corresponding LOD values of 0.5 and 0.3 µM. Shehab et al. designed a
non-enzymatic glucose sensor with the use of phenylboronic acid receptor-modified GQDs, where the
PL of GQDs was considered as the crucial optical parameter for glucose [167]. This sensor could exhibit
a good linear relationship for glucose concentrations, ranging from 4 to 40 mM (~72 to 720 mg dL−1),
with an LOD value of 3.0 mM.
As shown in Figure 7, Huang and the group introduced a novel PL-based electron-transfer method,
depending upon the quenching of various transition metal ions on the PL intensity of GQDs [168].
In this work, ethylene diamine tetra-acetic acid (EDTA) could competitively interact with metal ions
for restoring the quenched PL of GQDs. It was experienced that those metal ions with empty or fully
filled d-orbits could not quench the PL emission intensity of GQDs, but those with partly filled d-orbits
Sensors 2020, 20, 1072 16 of 71
could do so. With these facts, an optical metal sensing system was designed by considering Ni2+ as a
model analyte and by employing Ni2+-specific chelating reagent (i.e., dimethyl-glyoxime) to substitute
EDTA, which could estimate the Ni2+ concentration with an LOD of 4.1 µM.
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Ananthanarayanan et al. exemplified a GQD-based PL strategy for sensing Fe3+ ions [169]. In this
research, 0D GQDs were chemically prepared from 3D graphene by the vapor deposition method,
where the sensor was capable of detecting Fe3+ ions, ranging from 0 to 80 µM and an LOD of 7.22 µM.
Another PL-sensor for Fe3+ ions was reported with even lower LOD value (i.e., 5 nM). [170]. In this
work, GQDs were synthesized by carbonizing the precursors of polycyclic aromatic hydrocarbon
(PAH) precursors with strong acid and, consecutively, by reducing hydrothermally with the use of
hydrazine hydrate. In 2016, an environment-friendly approach using coffee beans and a hydrazine
hydrate-associated hydrothermal method for synthesizing GQDs was reported for Fe3+ and Cu2+
ions [171]. These GQDs were then modified with polyethylene imine that displayed improved
band-edge PL with single exponential decay. Moreover, this sensing platform could be able to detect
Fe3+ as well as Cu2+ ions with an LOD of 1 µM for both. Sun et al. fabricated a PL based GQD-sensor
that could quantify the lowest concentrations of Cu2+ ions with the detection limit of ca. 7 nM, which
could be due to the involvement of amino-modified GQDs [172].
Bai and co-workers established a PL sensor for detecting phosphate ions using GQDs [173].
The off–on sensing principle depended on the combination of GQDs and Eu3+ ions, where phosphate
ions could be detected by competing O2-donor moieties from phosphate ions with those from the ester
(RCOOR’) groups on the GQD-surface for Eu3+ ions. This sensor could display a broad linear response
between the increased PL intensity of GQDs and phosphate ions in the range of 0.5–190 µM, with an
LOD of 0.1 µM.
In 2017, Patra and colleagues presented the preparation of GQDs combined with graphene, where
the GQDs were hydrothermally sourced from carrot juice [174]. In order to achieve the maximum PL
intensity from graphene/GQDs, the graphene sheets were chemically modified with cadmium sulphide
(CdS). This nanohybrid material was then functionalized to induce multi-functionalities, for an instance,
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initiation of polymerization and imprinting of nimesulide polymer. This MIP-sensor could detect
nimesulide, with an LOD down to 6.65 ng L−1 and can be clinically applied for tracking nimesulide in
complex biological matrices including human blood serum, urine samples and pharmaceutical tablets.
2.3. Chemiluminescence-Based GQD-Sensors
Chemiluminescence (CL) is the emission of light (luminescence) and/or heat via a chemical
reaction. CL can assure high sensitivity (10−6–10−15 g), and lower detection limits (10−18 g) [175]. CL
can be deprived of selectivity when it is used directly as a spectrometric method. The instrumentation
of CL sensors is pretty simple. Although CL-based biosensors may provide good sensitivity, their
selectivity is not good enough. It is therefore essential to improve the selectivity of the CL reaction in
the future. The merits of CL sensors are the broad dynamic ranges, quite low detection limits, as well as
the comparatively facile instrumentation needed. CL is used as a mechanism that allows quantification
of several biomolecules at minimum concentrations. Demerits of such biosensors include insufficient
sensitivity and selectivity due to several physical and chemical parameters [176]. Hence, to the best of
our knowledge, very few CL based GQD sensors have been developed so far.
Amjadi et al. presented a GQDs-Ce (IV) CL system to quantify uric acid in urine and plasma
samples, where the CL of GQDs was generated by direct chemical oxidation [177]. In the study, GQDs
were synthesized by a simple carbonization method and characterized by X-ray diffraction (XRD),
Fourier transform infrared spectroscopy (FT-IR), transmission electron microscopy (TEM) and Raman
spectroscopy. The fluorescence and CL emission spectra were tracked to study the CL generation
mechanism, since Ce (IV) can oxidize GQDs to induce a relatively intense CL emission as well as
considering the combined property of the radiative oxidant-injected holes and thermally excited
electrons in GQDs. This analytical model could determine uric acid, based on its diminishing effect on
the GQDs-Ce (IV) CL system, which showed a wide linear response from 1.0 × 10−6 M to 5.0 × 10−4 M
with an LOD of 5.0 × 10−7 M. Later, the same group synthesized MIP@N-GQDs using a facile sol–gel
phenomenon for sensing doxorubicin, an anti-cancer drug [178]. Potassium permanganate (KMnO4)
was added to the MIP@N-GQDs solution, which emitted a strong CL and on injecting doxorubicin,
the CL intensity was considerably quenched to establish a CL detection system for this drug (Figure 8).
The mechanism behind the MIP@NGQDs/KMnO4 CL system was examined by studying fluorescence,
CL as well as ultraviolet–visible (UV–Vis) spectra. The relative CL intensity suppressed in a linear
fashion with the doxorubicin concentration over a wide range of 20–260 mg L−1 and an LOD value of
4.7 mg L−1 was obtained. This strategy was applied for determining therapeutic levels of doxorubicin
in a spiked human serum sample.
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Figure 8. Construction of MIP@N-GQDs based chemiluminescence (CL) sensor for the quantification
of doxorubicin [178]. Reproduced by permission of The Royal Society of Chemistry. APTES:
Aminopropyltriethoxysilane; TEOS: Tetraethoxysilane.
In 2017, Chen and co-workers demonstrated a Cu2+ catalyzed persistent CL sensor for ascorbic
acid (AA) determination [179]. This system was constructed using N-GQDs as a green luminophor,
which could emit CL with the direct oxidation by H2O2. Additionally, the Cu2+ ion offers distinct
specificity against other interfering metal ions and inflates over twice the CL intensity of N-GQDs,
owing to its catalytic Fenton-like reaction for H2O2 decomposition. As a result, the scintillating
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luminescence of N-GQDs was augmented and then varied to retain perpetuity with minute decay
in the existence of the Cu2+ ion, possessing the ability for CL visual imaging. This sensor based on
Cu2+/N-GQDs/H2O2 provided quantitative analysis of AA in fruit, displaying a dynamic range and an
LOD of 1–100 µM and 0.5 µM, respectively.
In 2018, Hassanzadeh and Khataee introduced a novel non-enzymatic sensor to monitor the
cholesterol level in human serum [180]. The approach aimed at a synergetic peroxidase-mimicking
effect, disclosing the significance of GQDs and mixed MoS2 quantum dots (MoS2 QDs), where the
intense catalytic activity of these QDs was studied on the basis of CL and the concurrent existence of
this mixture was recognized by the reaction of H2O2-rhodamine B (RB) via their CL emission intensity.
The authors reported a linear calibration between the CL emission intensity and H2O2 levels in the
range of 1.5–460 nmol L−1. Nevertheless, this system was investigated to determine oxidation of
cholesterol by an enzyme called cholesterol oxidase (ChOx), with regard to the enzymatic oxidation
of cholesterol for the H2O2 production. This CL system attained a further enhancement by MoS2
nanosheets that improved the efficiency of ChOx in the cholesterol oxidation process and offered very
sensitive and selective detection of cholesterol in a linear concentration (i.e., 0.08–300 µmol L−1), and
estimated an LOD value of about 35 nmol L−1.
Al-Ogaidi and team fabricated a GQD-immunosensor for quantifying the ovarian cancer biomarker
CA-125 [181]. The sensor development involved the implantation of GQDs on a modified glass electrode,
where the transduction of a resultant signal depended on the chemiluminescence resonance energy
transfer (CRET) from the CL reagent. This CL reagent had good solubility in an aqueous media
containing GQDs. The GQDs were employed as the energy acceptor, which prevented photo-bleaching
occurring with organic dyes. Moreover, the GQDs facilitated the nano-surface energy transfer (NSET)
mechanism, which does not need the spectral overlapping of the energy acceptor and the donor.
Bio-immobilization of the capture antibody onto the GQDs-functionalized surface revealed an ability
to promote high-throughput and automated sensing platforms. The fabrication strategy of this CL
immuno-chip and the detection mechanism for CA-125 are depicted in Figure 9. The amino-modified
glass chips were silanized with a 3-aminopropyl-trimethoxysilane (APTMS) layer, followed by the
GQD coating through the electrostatic attraction of a positively charged amine group within the
polydimethylsiloxane (PDMS) stencil. The specific CA-125 capture antibody (cAb) was then covalently
immobilized on GQD-modified glass chip via amide chemistry. Also, bovine serum albumin (BSA)
was added to clog the unreacted sites to form the GQDs–cAb chip. In the absence of CA-125 antigen,
the generation of the reactive oxygen species (ROS) was catalyzed from H2O2 by virtue of an enzyme
(i.e., HRP). Subsequently, this ROS could oxidize luminol to a pair of dianions, producing the electrons
in an excited state. At the same time, the intensity of the emitted blue light was tracked by a fluorescence
plate reader. On the other hand, in the presence of CA-125, the immunocomplex interacted with HRP
and the dianion catalyzed by the HRP promoted the resonance energy transfer (RET) to the GQDs,
leading to the quenched CL intensity. Thus, the CL intensity was found to be reciprocated to the
CA-125 concentration. The resultant CL intensity obtained a linear correlation of CA-125 concentration,
i.e., 0.1 to 600 U mL−1, where an LOD of 0.05 U mL−1 was achived in buffer. For analyzing the clinical
performance of the as-prepared sensor, the CL intensity was tracked from the specimen comprising
human blood plasma and buffer in 1:1 proportion, which could give an LOD of 0.08 U mL−1.
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2.4. Electrochemiluminescence-Based GQD-Sensors
Electrochemilumin s nce (ECL) involves electro-generation of CL, which acquires the merits of
both PL and electrochemical techniques [182,183]. An ideal ECL sensor employs three electrodes; i.e.,
a reference electrode (RE), a counter electrode (CE) and a working electrode (WE). The electrochemical
reaction that occurs on the WE leads to a particular CL reaction. In a broader range, a material is
illuminated in an excited state through an electron transfer on the electrode’s surface. Consequently,
the conversion of an excited state into the ground state (i.e., from unstable to stable) leads to the
emission of light. Accordingly, the formation of the free radicals in ECL occurs, which are segregated
into the co-reaction and quenching pathways [184–186]. ECL sensing techniques exhibit excellent
features including high sensitivity, rapid speed of response and easy operational procedures. Moreover,
they have been acutely employed for sensing numerous proteins, nucleic acids and metal ions. With
reference to the fluorescence methods, ECL does not need an excitation light source, thus it avoids a
scattered light background or auto-fluorescence [185,187,188]. Applied electric potential induces and
controls the output signal for assuring the accuracy as well as the reproducibility of ECL. Moreover,
GQDs have been witnessed as excellent ECL labeling agents for developing the GQD-sensors, especially
because of their bio-compatibility and low cytotoxicity [189].
Wu and coworkers assembled an ECL antibody sensor to determine prostate-specific antigen
(PSA) involving GQDs as electrode enhancers [190]. Reinforcement of acarboxyl and NH2–GQDs
on reduced graphene oxide (rGO)-Au/Ag NPs resulted in a considerable improvement of electrode
surface as well as enhanced the conductivity that boosted the ECL signal. Nevertheless, subsequent
bio-immobilization of anti-PSA antibodies dropped the ECL intensity due to the adsorbed Au/Ag.
The as-formulated label-free sensor could determine PSA with an LOD of 0.29 pg mL−1, granting a
linearity from 1 pg mL−1 to 10 ng mL−1. Another antibody sensor was proposed by Yang et al. for
the detection of carbohydrate antigen 199 (CA 199) in human serum [191]. Figure 10 displays the
construction steps of a sandwich assay involving the use of GQDs decorated with a porous PtPd
nanochain (GQDs-PtPd) and Au-Ag NPs-functionalized graphene (Au-Ag-GN) on GCE. By virtue of
the physical and chemical characteristics offered by such hybrids, Au-Ag-GN delivered abundant sites
for capturing primary antibodies and increased the conductivity, whereas GQDs-PtPd provided a large
free room for immobilizing secondary antibodies. The as-fabricated sensor could reliably quantify CA
199 molecules down to 0.96 mU mL−1 and achieved a linear calibration plot from 0.002 to 70 U mL−1.
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The stability studies revealed that the modified GCE could retain around 96% of its initial activity even
after 50 days. This stable behavior can be ascribed to the higher affinity of GQDs-PtPd for the secondary
antibodies as well as good biocompatibility of the nanocomposites. Moreover, it was reported that this
antibody sensor can be clinically employed to diagnose patients with pancreatic cancer.
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Carcinoembryonic antigen (CEA) is considered a t ro inent tumor biomarker for diag osing
various malignancies [192–197]. CEA is basically a glycoprotein with the size 180–200 kDa [198] and
its expression and over-expression generally occur in mucosal cells and in several oncofetal tumor
cells, respectively [199,200]. A rise in plasma CEA levels (i.e., >5 × 10−9 g mL−1) indicates the growth
of cancerous cell [195]. In 2018, Nie et al. developed an ECL immunosensor employing GQDs for the
quantification of CEA [201]. In their approach, the sensor construction held integration of GQDs in
conjugation with AuNPs and electrochemically reduced graphene oxide/poly(5-formylindole) hybrids
(erGO/P5FIn). Being a adequate matrix, rGO/P5FIn nanomaterial promotes the transport of ions
during the occu rence of oxidation and reduction re ctions, which provides a greater surface area to
implant more primary anti-CEA receptors. At the same time, both AuNPs and GQDs (i.e., as labels)
enhance electron transferability upon their conjugation with the secondary anti-CEA receptors. With
the help of these signaling species (i.e., AuNPs/GQDs and erGO/P5FIn), the resultant sandwich-based
antibody sensor could respond in the linear array from 0.1 pg mL−1 to 10 ng mL−1 CEA in a human
serum, with an achievement of around 3.8 fg mL−1 as the detection limit.
On the basis of highly selective polydopamine (PDA) imprinted polymer and ECL properties of
N-GQDs, an emphatically engineered biosensing platform was developed [202]. This platform was
intended to det ct the pervasive micro-organism E. coli, w re the sensor preparation involved direct
electr polymerization of PDA and the target bacteria to devel p a PDA-MIP film on the surface of GCE.
Thereafter, to get rid of the bacterial template, the as-formed PDA-MIP/GCE underwent overnight
incubation in a solution containing sodium dodecyl sulfate (SDS) and acetic acid. Correspondingly,
N-GQDs labeled specific polyclonal antibody was used for recognizing the target bacteria (i.e., E. coli).
The stepwise characterization of the established electrode was performed using cyclic voltammetry
(CV) and electron impedance spectroscopy (EIS). This sandwich assay was sensitive and selective
for wide range of E. coli concentrations, i.e., from 10 to 107 cfu mL−1. Moreover, the detection limit
revealed by this sensor was 8 cfu mL−1, when employed for the environmental water specimen.
Lu et al. prepared graphitic structured nanocrystals of bright blue luminescent GQDs with QY
of 15.5% for detecting DNA damage [203]. The research work involved the synthesis of GQDs by
combining ultraviolet irradiation, thermal reduction and oxidation-cleavage, which exhibited stable
ECL as well as excitation-dependent PL. During the sensor development, a cp53 ssDNA probe was
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conjugated with AuNPs to forge an ssDNA-AuNPs complex. The ECL signal intensity was dynamically
quenched by non-covalent binding of ssDNA-AuNPs complex with the GQDs, owing to the ECL-RET
taking place between AuNPs and the GQDs. Subsequent hybridization of target p53 DNA with
ssDNA-AuNPs led to the formation of dsDNA-AuNPs and impairment of non-covalent binding
between ds-DNA and GQDs. As a result, the ECL intensity of GQDs was restored, inducing an ECL
sensing system for the target p53 ssDNA detection with an LOD and a calibration plot of 13 nM and
25–400 nM, respectively. Depending on the distinct bonding capacity for the cp53 ssDNA-coupled
AuNPs and mutant target p53 ssDNA, the prepared sensor can be applied for monitoring DNA
damage. The authors claimed that this method can also be employed for establishing similar methods
to determine aptamer-specific target analytes or/and polymorphisms with one-nucleotide.
In 2017, Zhou et al. explored the role of GQDs as alluring ECL luminophores for the detection
of glucose and H2O2, where sulfite (SO32−) served as a reducing agent (i.e., co-reactant of GQDs’
ECL) [204]. Nevertheless, it was reported that GQDs produced stronger ECL emission (approximately
4 fold), when compared to that of spherical carbon quantum dots with SO32− as the co-reactant.
This could be attributed to numerous surface states of GQDs. Further examination revealed that H2O2
could significantly quench GQD/SO32− ECL via a second-order redox reaction between H2O2 and
SO32− under physiological pH. Given this fact, a green and facile ECL biochemical sensing system
has been introduced for the determination of biomolecules like glucose and H2O2. The mechanism of
the GQD/SO32− ECL system involved anodic generation of strongly oxidizing radicals (SO4•-) and
excited-state GQDs (GQDs*). The linear calibration plot displayed the glucose concentration from 10
to 100 µM, where an estimated LOD of 5.0 µM was achieved.
Tian and team proposed an ECL glucose sensor [205]. Prior to the sensor development, <10 nm
sized GQDs were synthesized from GO sheets by treating them with photo- and sono-chemicals,
where the synthetic procedure involved H2O2 as a solely used chemical compound. On applying
cyclic voltammetry to GCE containing potassium persulfate (K2S2O8) and GQDs, a strong cathodic
ECL signal was generated. Furthermore, while investigating the ECL behavior of GQDs/K2S2O8
co-reactant system, it was found that the ECL signal was significantly based on the reduction of GQDs
and dissolved O2. Moreover, a product of enzymatic glucose oxidation (i.e., H2O2) quenched the
signal intensity. Hence, following this mechanism, a glucose sensor based on the ECL mechanism was
established by modifying GCE surface through adorning a layer of GQDs, GOx and chitosan, where
the ECL intensity of glucose concentration depressed linearly from 1.2 to 120 pmol L−1, with an LOD
of 0.3 pmol L−1.
Liang et al. fabricated a novel ECL-RET biosensor, exploiting the significance of GO as acceptor and
GQDs as donor to monitor protein kinase activity [206]. A nanocomposite comprising GO–conjugated
with anti-phosphoserine antibody (Ab-GO) was integrated onto the GQDs/phosphorylated peptide
modified electrode via an immunoreaction with ATP and CK2. As a result, an ECL signal correlating
with CK2 activity was generated due to the quenching of GQDs connected with GO. The ECL signal
decreased in accordance with the increase in CK2 level from 0.05 to 5 U mL−1, which demonstrated
0.023 U mL−1 being the detection limit. This approach was further studied for characterizing the
inhibition of CK2 activity, taking ellagic acid as a model inhibitor. Here, the ECL signal attained
saturation over 0.15 µM ellagic acid and, thereby, the IC50 value for ellagic acid was computed to be
0.043 µM. Moreover, to study the specificity of the assay, various enzymes and proteins like glucose
oxidase, alcohol dehydrogenase and BSA were experimented on. The results showed negligible
variation in ECL intensity for GOx, alcohol dehydrogenase (ADH) and BSA, as compared to CK2,
suggesting high selectivity of this biosensor for CK2. Henceforth, the protein kinase activity could be
determined sensitively leaning on ECL-RET between GQDs and GO. The proposed ECL-RET-based
biosensing strategy can be employed in clinical diagnosis and biochemical fundamental studies to
screen kinase inhibition as well as to analyze CK2 activity in serum samples, implying its prominent
qualitative and quantitative analytical applications.
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A simple ECL signal-on strategy exploring the role of N-GQDs and chitosan was designed for
detecting nitroaniline (NA) in real water samples [207]. Owing to the hydrophilicity, high water
permeability and strong adhesive characteristics of chitosan, it successfully loaded the N-GQDs to
the surface of the working electrode, while N-GQDs were used for the rapid diazotization reaction of
anilines and as highly reactive agent. As shown in Figure 11, on introducing NA to the electrolyte
solution containing sodium nitrite (NaNO2) and mineral acid (HCl), N-GQDs/chitosan modified GCE
led to an amplified ECL signal because of the diazotization event taking place. Hence, the target
analyte could be detected with excellent selectivity using the chitosan/N-GQDs ECL-sensing platform
in a linear ECL signal response of NA (i.e., 0.01 to 1 µmol L−1). With this, the calculated value of an
LOD was around 0.005 µmol L−1.
Sensors 2020, 20, x FOR PEER REVIEW 22 of 70 
 
permeability and strong adhesive characteristics of chitosan, it successfully loaded the N‒GQDs to 
the surface of the working electrode, while N‒GQDs were used for the rapid diazotization reaction 
of ilines and as highly r active agent. As show  in Figure 1, on i t cing NA to the electrolyte 
solution co taining sodium nitrite (NaNO2) and mineral acid (HCl), N‒GQDs/chitosan modified 
GCE led to an amplified ECL signal because of the diazotization event taking lace. Hence, the target 
analyte could be detected with excellent selectivity using the chitosan/ N‒GQDs ECL-sensing 
platform in a linear ECL signal response of NA (i.e., 0.01 to 1 µmol L−1). With this, the calculated value 
of an LOD was around 0.005 µmol L−1. 
 
Figure 11. Detection strategy of nitroaniline by N‒GQDs and chitosan functionalized glassy carbon 
electrode (GCE) [207]. 
Yan and colleagues proposed an in situ methodology for synthesizing GQDs implanted with the 
nanospheres of Cu2O [208]. The characterization of this nanomaterial was achieved by XRD, TEM as 
well as X-ray photoelectron spectroscopy. Moreover, on the basis of GQDs-Cu2O nanospheres, a 
novel method for the amplification of the ECL signal of luminol system was studied, which inferred 
that using GQDs, the catalytic activity of Cu2O nanospheres was enhanced towards luminol oxidation 
(~3.5 times), rather than using only Cu2O nanospheres. Also, the ECL onset potential decreased by 
130 mV. This could be ascribed to the enhanced electron transferability of GQDs. With these facts, 
they fabricated a model for the selective identification of a pesticide, pentachlorophenol (PCP) that 
strives an inhibitory effect on the ECL, which provided an LOD value of 6.6 pg mL−1 and could sense 
PCP in a dynamic linear range (i.e., 0.02 to 300 ng mL−1). 
Depending on the ECL amplifying characteristics of CdS–GQDs nanocrystals (CdS–GQDs NCs), 
an ultrasensitive ECL sensor was designed by Liu et al. for the recognition of PCP contamination in 
water [209]. Because of the existing doped GQDs, the ensuing CdS–GQDs NCs not only displayed 
five times increase in ECL sensor response than plain CdS NCs, but also resulted in a negative shift 
in ECL onset potential by 80 mV. Accounting for the selective inhibitory effect of PCP on the ECL 
intensity of GQDs–CdS NCs, this facile method could achieve an LOD of 3 pg mL−1 and determined 
PCP concentration in a dynamic linear array of 0.01–500 ng mL−1 with good reproducibility as well 
as long-term stability. 
Another ECL method for sensing PCP in water was introduced by Du and colleagues [210]. In 
this approach, preparation of N‒GQDs was conducted via a simple hydrothermal technique 
involving the dissection of nitrogen-doped graphene, and thereafter N-doped GQDs were uniformly 
functionalized onto the graphene oxide (GO) surface to obtain NGQDs-GO nanocomposites. The as-
synthesized N‒GQDs with GO as the immobilization support possessed excellent ECL behavior i.e., 
a 3.8-fold higher ECL response than simply using N‒GQDs, and also led to a decreased ECL onset 
potential by 200 mV. This ECL sensor could identify PCP concentration in a linear range, i.e., from 
Figure 11. Detection strategy of nitroaniline by N-GQDs and chitosan functionalized glassy carbon
electrode (GCE) [207].
Yan and colleagues proposed an in situ methodology for synthesizing GQDs implanted with the
nanospheres of Cu2O [208]. The characterization of this na o aterial was achieved by XRD, TEM as
well as X-ray photoelectron spectroscopy. Moreover, on the basis of GQDs-Cu2O nanospheres, a novel
method for th amplification o the ECL signal of luminol system was studie , which inferred that
using GQDs, the catalytic activity of Cu2O nanospheres was enhanced to ards luminol oxidation
(~3.5 times), rather than using only Cu2O nanospheres. Also, the ECL onset potential decreased by
130 mV. This could be ascribed to the enhanced electron transferability of GQDs. With these facts, they
fabricated a model for the selective identification of a pesticide, pentachlorophenol (PCP) that strives
an inhibitory effect on the ECL, which provided an LOD value of 6.6 pg mL−1 and could sense PCP in
a dynamic linear range (i.e., 0.02 to 300 ng mL−1).
Depending on the ECL amplifying characteristics of CdS–GQDs anocrystals (CdS–GQDs NCs),
an ultrasensitive ECL sensor was designed by Liu et al. for the recognition of PCP contamin tion in
water [209]. Because of the exi ting doped GQDs, the ensuing CdS–GQD NCs ot only displayed
five times increase in ECL sensor response than plain CdS NCs, but also resulted in a negative shift
in ECL onset potential by 80 mV. Accounting for the selective inhibitory effect of PCP on the ECL
intensity of GQDs–CdS NCs, this facile method could achieve an LOD of 3 pg mL−1 and determined
PCP concentration in a dynamic linear array of 0.01–500 ng mL−1 with good reproducibility as well as
long-term stability.
Another ECL method for sensing PCP in water was introduced by Du and colleagues [210]. In this
approach, preparatio f N-GQDs was conducted via a simple hydrothermal technique involving the
dissectio of nitrogen-doped graphene, and thereafter N-doped GQD w re uniformly functionalized
onto the graphene oxide (GO) surface to obtain NGQDs-GO anoc mposites. The as-synthesized
N-GQDs with GO as the immobilization support possessed excellent ECL behavior i.e., a 3.8-fold
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higher ECL response than simply using N-GQDs, and also led to a decreased ECL onset potential by
200 mV. This ECL sensor could identify PCP concentration in a linear range, i.e., from 0.1 to 10 pg mL−1.
Here, the detection limit was quantified down to 0.03 pg mL−1. When we compared its features with
both of the ECL sensors reviewed above for PCP, it was observed that this sensor exhibited 100- to
220-fold lower detection limits. Such an ultra-sensitivity can only be achieved because of the presence
of GO apart from GQDs.
Dong et al. reported an ECL system for the selective determination of lead (II) ions (Pb2+) using
single-layer GQDs and L-cysteine (L-Cys) [211]. This L-Cys/GQDs co-reactant system generated a
strong cathodic ECL signal depending on some critical parameters such as oxidation of L-Cys, reduction
of GQDs and the presence of dissolved O2. Besides, it was found that Pb2+ could quench the ECL
signal of the L-Cys/GQDs system. The authors reported that this methodology can deliver a quick and
reliable strategy for Pb2+, with an LOD of 70 × 10−9 M and a wider linear response of 100 nM–10 µM.
In 2019, Jie et al. developed an enhanced ECL approach for the DNA analysis. As shown in
Figure 12, this method was based on the ECL activity of GQDs associated with a multiple cycling
amplification strategy [212]. The uniform GQDs were synthesized and then immobilized on the
electrode surface by graphene oxide/poly-diallyldimethylammonium chloride (GO/PDDA) hybrid
material that amplified the ECL signal and stability of GQDs. This signal-on ECL system for detecting
DNA employed ECL quenching from AuNPs to GQDs coupled with an endonuclease-aided cyclic
amplification strategy. Moreover, this biosensor could detect target DNA in a wide linear range
(i.e., 1.0 × 10−12 M–1.0 × 10−6 M), with the quantification limit of 0.1 × 10−12 M and can be further
expanded for other biosensing applications, particularly in clinical diagnosis.
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A mono-luminophor ECL sensor using N-GQDs was established for the ratiometric sensing of
Co2+ ions in real water samples [213]. Dissolved O2 converted to O2− and HO2− aided in generating
anodic and cathodic ECL signals of N-GQDs, while Co2+ ions could clearly enhance the ECL intensity
at the anode through the catalytic performance occurring during the transitional period, and could
quench the ECL intensity at the cathode due to its considerable removal from N-GQDs*. Thus,
the Co2+ ions were determined by analyzing the ratiometric excitation potentials. With these findings,
a dual-potential label-free ratiometric ECL sensing system for Co2+ ions was manufactured with high
sensitivity and selectivity against other interfering metal ions such as Cu2+, Fe2+, Hg2+ and Ni2+ ions.
The as-fabricated ECL-sensor provided a linear signal response for Co2+ ions (i.e., 0.001–0.07 M), with
an LOD of 0.2 mM.
Lu et al. designed an ECL aptasensor for determining adenosine triphosphate (ATP) [189].
The study involved the hydrothermal preparation of water-soluble GQDs through disintegration and
exfoliation treatments with GO. The as-synthesized GQDs presented an intense blue light through a UV
irradiation (~365 nm) that exhibited a PL property. An ECL emission with a strong light was generated
at anode (Ag/AgCl vs. ~0.4 V). Furthermore, SiO2 nanospheres were used as signaling species and,
therefore, GQDs/SiO2 ECL labels were developed for an ultrasensitive ECL aptasensor, which could
detect ATP in a near-linear relationship between 5 p mol L−1 to 5 n mol L−1. This aptasensor achieved
an LOD of 1.5 p mol L−1. Further examples of ECL-based GQD-sensors are listed in Table 3.
Sensors 2020, 20, 1072 25 of 71
Table 3. Various other ECL-sensors for biomedical applications (2015 onwards).
Electrode Nanomaterials Receptor Type Receptor Target Analyte Specimen Linear ConcentrationRange Detection Limit Reference
GCE HM–S–GQDs Nucleic acid Hemin/G-quadruplexDNAzyme p53-gene Buffer 100 fM–100 nM 66 nM [214]
GCE GQDs Oligosaccharide β-CD L-Tyr;D-Tyr Human serum
6–100 µM
0.1–1 mM
6.07 × 10−9 M
1.03 × 10−7 M [215]
GCE N–GQDs@SiO2 NPs Nucleic acid Aptamer OTA Peanut sample 1 × 10−3–10 ng mL−1 0.5 × 10−3 ng mL−1 [216]
GCE MoS2-GQDs MIP
MCPA imprinted
polymer MCPA
Lake water;
Tap water;
Oat samples
10 pM L−1–0.1 µM L−1 5.5 pM L−1 [217]
GE GQDs Nucleic acid DTC-DNA probe HCV- 1b Buffer 5 fM–100 pM 0.45 fM [218]
GCE NH2–PTCA/Au@Fe3O4/GQDs
Nucleic acid DNA miRNA
Buffer; Hela,
HK-2, LO2,
22Rvl cell lines
2.5 fM–50 pM 0.83 fM [219]
GCE AuNPs/HM-S-GQDs Antibody Anti-CEA CEA Buffer 0.02–80 × 10−9 g mL−1 0.01 × 10−9 g mL−1 [220]
Pt. B–GQDs@AuNPs Nucleic acid DNA miRNA-20 a Human serum 0.1–1 × 104 pM 0.1 pM [221]
GCE Agcore@AushellNPs/GQDs Nucleic acid DNA lnc-RNA Human serum 1 fM–5 nM 0.3 fM [222]
Abbreviations: 22Rvl: Prostate carcinoma cell line; β-CD: β-Cyclodextrin; AuNPs: Gold nanoparticles; B-GQDs: Boron-doped GQDs; CEA: Carcinoembryonic antigen; DNA:
Deoxyribonucleic acid; DPV: Differential pulse voltammetry; DTC: Dithiocarbamate; Fe3O4: Ferrous ferric oxide; GCE: Glassy carbon electrode; GE: Glass electrode; GQDs: Graphene
quantum dots; HCV-1b: Hepatitis-C virus- 1b; Hela: Cervical cancer cell line; Hg2+: Mercury (II) ion; HK-2: Human renal cubular epithelial cell line; HM-S-GQDs: Hydrazine modified
single layer GQDs; MCPA: 2-methyl 4-chlorophenoxyacetic acid; MIP: Molecularly imprinted polymer; miRNA: microRNA; MoS2-GQDs: Molybdenum sulfide GQDs; N-GQDs:
Nitrogen-doped GQDs; NH2–PTCA: aminated–3,4,9,10–Perylenetetracarboxylic acid; lnc-RNA: long non-coding RNA LO2: Normal hepatocyte cell line; OTA: Ochratoxin-A; p53: Tumor
protein-53; Pt.: Platinum; SiO2 NPs: Silica nanoparticles; Tyr: Tyrosine.
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2.5. Fluorescence Resonance Energy Transfer (FRET)-Based GQD Sensors
Technically, FRET is a phenomenon that transfers radiation-free energy from one fluorophore to
another, i.e., from a donor to an acceptor. In a broader range, the energy from the excitation light source
is absorbed by the donor and non-radioactively transferred to the acceptor, resulting in an emission of
fluorescence. This distance-dependent feature is employed for the examination of structural variations
during the bio-recognition events [223]. FRET-dependent sensors have been employed to monitor the
cell-dynamics in heterogeneous cellular populations as well as to study on-site single-cell concentration.
In spite of their divergent biomedical applications, such sensors still face some challenges. Hence,
there is a huge demand for the enhanced sensitivity as well as for the higher fluorescence resolution of
FRET biosensors [11].
As represented in Figure 13, Qian and co-workers reported an ultrasensitive DNA nanosensor based
on FRET between bio-compatible GQDs and CNTs for the quantitative analysis of target DNA, [224,225].
Herein, the fabrication strategy was implemented by considering: (a) the base-coupling particularity of
DNA, (b) distinct FRET between CNTs and DNA, (c) strong fluorescence and excellent biocompatibility
of GQDs. In this approach, oxidized CNTs and GQDs with QY up to 0.21 were synthesized as a
capable quenching agent and fluorophore of a DNA probe, respectively. FRET between oxidized
CNTs and a GQD-labelled probe was attained by the virtue of their self-assembly via pi–pi stacking.
Typical “on-off-on” fluorescence was induced from fluorescence quenching (30 min) due to FRET
between GQDs and CNTs as well as consequent fluorescence recovery (30 min) owing to the released
probe of free double stranded (ds) DNA. The as-developed nanosensor could differentiate mismatched
and complementary nucleic acid sequences with high sensitivity and acceptable reproducibility.
The detection strategy based on this nanosensor acquired a wide linear response and an LOD of 1.5–133
nM and 0.4 nM, respectively.
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Acid phosphatase (ACP), a prevalent digestive enzyme, is highly specific for hydrolyzing the
phosphate esters under an acidic environment [226]. Generally, the human ACP level is low in
mammalian cells, but prostate cancer, colon cancer, Gaucher disease, renal disorders, diseases related
to veins and bones are usually tailgated by changes in the ACP concentrations [227,228]. Clinically,
the ACP activity is measured to diagnose cancers and to monitor cell viability. Na et al. developed a
new and efficient fluorescence method for selectively and sensitively determining ACP activity [229].
This bio-sensing system was constructed by linking GQDs to Nile red (NR) through a complex of
β-Cyclodextrin/lecithin (β-CD/lecithin). The coexistence of β-CD/lecithin as a linker molecule, would
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bring a pair of NR–GQDs together via hydrophobic as well as electrostatic interactions, resulting in
FRET and, thereby, fluorescence enhancement and quenching of an acceptor and donor (i.e., NR and
GQDs), respectively. The ACP could hydrolyze lecithin into 2 fragments, which could separate a pair of
NR–GQDs. This FRET sensor was clinically applied for ACP imaging in prostate cancer cells (PC-3M),
which could detect very low concentration of ACP with an LOD of 28 µU mL−1. Moreover, the authors
reported that the tolerable concentration ratios of other interfering compounds to 100 µU mL−1 ACP
was 10 times higher for ATP, ALP, Try, Lys and GSH, suggesting the as-developed strategy is quite
selective for ACP.
A homogeneous assay for quantifying DNA in the case of transgenic soybean, based on FRET,
was exemplified for cauliflower-associated mosaic virus 35s (CaMV35S) [230]. The assay involved
DNA hybridization with a probe functionalized by AgNPs and N-GQDs (i.e., acceptor-donor pairs).
The highly conducive FRET and distinct features of N–GQDs revealed an efficient FRET detection
platform for labeling DNA. Upon the specific target DNA (tDNA) recognition, the FRET between AgNPs
and NGQDs facilitated fluorescence quenching for tDNA detection. The as-developed homogeneous
FRET method exhibited a broad linear relationship between 0.1 and 500 × 10−9 M. The interpretation
of the low quantification limit for the detection of the CaMV35S promoter was reported as 0.03 nM.
This biosensor was highly specific for tDNA, with long-term stability and excellent intra-assay precision.
Moreover, this assay was applied to determine the real sample of transgenic soybean and was further
validated by polymerase chain reaction (PCR), indicating its feasibility to determine genetically
modified organisms for routine applications.
In 2018, Kong and co-workers engineered FRET based immunosensor for the quantification of von
Willebrand factor (vWF), a multimeric plasma glycoprotein. Initially, they synthesized Agcore@Aushell
nanoparticles (Ag@AuNPs) and GQDs that were then characterized by X-ray photoelectron spectra
and TEM, respectively [231]. During the assay development, vWF antibody was immobilized on
Ag@AuNPs to obtain the Ag@Au-antibody complex. This nanocomplex could readily quench the
fluorescence of GQDs by virtue of FRET. The immunoreaction occurring between Ag@Au-antibody
and vWF antigen led to decreased FRET efficiency as well as the fluorescence recovery of GQDs.
The variation in the resultant fluorescence emission was directly co-related with the logarithmic vWF
concentration (0.1 pg mL−1-10 ng mL−1), with the estimated LOD of 30 fg mL−1. This biosensor was
applied to study the vWF release pattern and the oxidation-injury profile of vascular endothelial cells,
where the experimental values suggested that the vWF content in the growth medium was elevated
and the cell injury was intensified due to the increased cellular contact with H2O2.
Poon et al. fabricated an efficient nanoprobe based on FRET for quantifying trypsin [232]. In this
approach, GQDs and CMR2 (i.e., coumarin derivative) were employed as a donor and as an acceptor,
respectively. BSA was utilized as a linker as well as a fluorescence enhancer of GQDs for the FRET
pair. During the presence of trypsin, this model would be devastated due to the digestion of BSA by
trypsin, resulting into the regeneration of an emission peak of the donor and an increased ratio of the
emission peak of the donor to the acceptor. On the basis of these ratiometric values, trypsin could be
quantitatively analyzed, where an estimated LOD was reported to be 0.7 µg mL−1 (i.e., 0.008 times the
mean value for trypsin concentration found in urine of the individuals suffering from acute pancreatitis).
The testing of intracellular GSH level in human serum has garnered meticulous attention due
to its vital role in several human pathologies. The development of a ‘turn off−on’ fluorescence
nanosensing system exploiting the attributes of MnO2 nanosheets and GQDs was reported to quantify
GSH levels [233]. In the study, MnO2 nanosheets could quench GQDs’ fluorescence through FRET.
Nonetheless, GSH could convert MnO2 nanosheets into Mn2+ via a reduction reaction and liberate GQDs,
resulting in fluorescence restoration. The MnO2 nanosheets could perform as a nano-quencher as well
as a GSH recognizer in the biosensor. The as-prepared sensing device could probe GSH concentrations,
ranging from 0.5 to 10 µmol L−1 and a minimum detectable concentration of 150 nmol L−1. Moreover,
the GQDs−MnO2 nanoprobe was highly selective for GSH against interfering biomolecules as well
as electrolytes.
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In 2018, a FRET-sensor using AuNPs as well as GQDs was proposed to evaluate glutathione
reductase (GR) activity in human [234]. The sensing mechanism followed several facts, which
included: (a) quenching of GQDs’ fluorescence emission intensity by AuNPs via FRET; (b) the role
of reduced GSH in preventing AuNPs from agglomeration and enlargement of the inter-particle
distance between AuNPs and GQDs that generates the fluorescent signal recovery; (c) weaker affinity
of AuNPs towards oxidized glutathione (GSSG) than towards GSH; (4) catalytic performance of GR to
convert GSSG into GSH in the existence of β-nicotinamide adenine dinucleotide 2’-phosphate hydrate
(NADPH). With such findings, a ‘turn-on’ bioassay could monitor GR activity in a linear fashion of
0.0050−0.13 mU mL−1 and provided an LOD of 0.0050 mU mL−1. This AuNPs−GQDs bioassay was
also validated for checking the inhibition activity of GR, with 1,3-bis(2-chloroethyl)-1-nitrosourea
(BCNU) being an illustrative molecule.
Sun and team proposed a biosensor for the diagnosis of cardiovascular diseases by considering
miRNA-34a as a model analyte [235]. The strategy worked on the principle of “off-on” through the use
of a GQDs probe coupled with gold nanoflower (AuNF). The authors reported that, when AuNF and
GQDs are at a distance of 4 nm and when the probe is coupled with a target miRNA, they result in
light-up sensitivity as well as fluorescence quenching efficiency and promote DNA circuit strategy.
The target miRNA-34a could be sensed to 0.1 fM with a wide linear response ranging from 0.4 to
4 fM. Another biosensing system for determining miRNAs using GQDs as well as pyrene-modified
molecular beacon probes (py-MBs) was demonstrated by Zhang et al. [236]. As portrayed in Figure 14,
pyrene was added for the specific induction of FRET between fluorescent dyes labeled with py-MBs
and GQDs through pi−pi stacking. The variation in fluorescent intensity could develop a novel signal
mechanism for determining the target miRNAs in a wide range (0.1–200 nM) and could give an LOD
value of 0.1 nM. The articulately developed FRET biosensor showed a new direction for detecting
small nucleic acids with multiplex detectability. Furthermore, the authors claimed that this biosensor
can be clinically convenient for diagnosing several cancer-types in their early stage.
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Fan and group conducted chemical synthesis of multicolored fluorescent GQDs from GO to 
develop a FRET-based sensing platform for 2,4,6-trinitrotoluene (TNT) [237]. Herein, the GQDs could 
bind TNT through π‒π stacking interaction between the aromatic rings and GQDs, which resulted 
into a decreased fluorescence intensity from GQDs to the non-radiative TNT (i.e., from donor to an 
acceptor). The unfunctionalized GQDs could quantify TNT in a broad linear range from 4.95 × 10−4 to 
1.82 × 10−1 g L−1, with the detection limit of 0.495 ppm (i.e., 2.2 mM) by using just a milliliter of GQDs 
solution. 
Figure 14. Biosensing system based on FRET change between GQDs and pyrene-modified molecular
beacon probes (py-MBs) for determining miRNAs [236].
Fan and group conducted chemical synthesis of multicolored fluorescent GQDs from GO to
develop a FRET-based sensing platform for 2,4,6-trinitrotoluene (TNT) [237]. Herein, the GQDs could
bind TNT through pi-pi stacking interaction between the aromatic rings and GQDs, which resulted
into a decreased fluorescence intensity from GQDs to the non-radiative TNT (i.e., from donor to an
acceptor). The unfunctionalized GQDs could quantify TNT in a broad linear range from 4.95 × 10−4
to 1.82 × 10−1 g L−1, with the detection limit of 0.495 ppm (i.e., 2.2 mM) by using just a milliliter of
GQDs solution.
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Shi and group conducted a FRET-based biosensing experiment, exploring the role of AuNPs as
well as GQDs for Staphylococcus aureus (S. aureus) specific gene sequence determination [238]. Herein,
reporter probes were fused on AuNPs and capture probes were implanted on GQDs, where these
nanomaterials acted as the energy acceptor and donor pairs, accordingly. To induce the FRET effect,
co-hybridization of the target oligonucleotides was carried out with reporter and capture probes that
could bring AuNPs and GQDs in close proximity. The initial and final fluorescence signal responses
were controlled, where the resulting quenching efficacy could attain almost 87% using only 100 nM of
the target oligonucleotides. An LOD could be achieved down to 1 nM for the target bacterial gene
identification. The selectivity studies with both mono-base and dual-base mismatched oligonucleotides
has shown the efficiency of this sensor in the real world.
Bhatnagar et al. fabricated a FRET-immunosensor based on amine functionalized GQDs to
diagnose myocardial infarction (MI) at its early stage [239]. In the research work, the anti-cTnI
antibodies were covalently attached to GQDs via 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide
(EDC) and N-hydroxysuccinimide (NHS). Characterization of this anti-cTnI/GQDs conjugate was
carried out using techniques like zeta potential UV–Vis spectroscopy and field-emission scanning
electron microscopy (FE-SEM). A detection efficiency associated with this immunosensor was examined
in accordance with the photoluminescence and variation in photon count of GQDs, which depended
on the recognition event between the target cTnI and anti-cTnI antibody. The authors reported that
this sensor displayed a minimum response to the other interfering antigens and provided a wide linear
relationship (i.e., 0.001–1000 ng mL−1), with an LOD of 0.192 pg mL−1. This antibody sensor could
quantify cardiac troponin (cTnI) biomarker within just a couple of minutes (precisely: 10 min).
An FRET-biosensor was constructed for detecting DA using poly-dopamine (pDA)-implanted
GQDs [106]. DA could be self-polymerized to pDA for developing a thin layer with GQDs in an
alkaline environment that resulted in fluorescence quenching due to FRET. Such a sensing platform
could respond sensitively to DA in a broad linearity, ranging from 0.01 µM to 300 µM, with an LOD of
8 nM in human serum.
3. Electrochemical GQD Sensors in Biomedical Diagnostics
Electrochemical sensors acquire a substantial ranking among commercially available sensors and
gained popularity in biomedicine [240–242]. This sensor type can act as a miniaturized device for
point-of-care testing (POCT) [243,244]. They are built upon a WE (i.e., transducer and recognition
system), a CE and a RE for computing the electrical signal response [245,246]. Among all the GQD-based
electrochemical sensors working on different kinds of receptors (i.e., antibody sensors, MIP-sensors,
DNA sensors, aptasensors and enzyme-based sensors), an antibody-sensing system has been widely
studied [79]. It is often known as an immunosensor, because its function is solely influenced by the
immunoreaction [247,248]. Such sensing platforms involve antibodies exhibiting excellent affinity for
their corresponding target biomolecules [11,79,249]. Taking immunoreactions into an account, typical
immunosensors can work on several assay-modes. (i.e., competitive, direct, sandwich or indirect
modes) [250–253]. Such assay formats work on the unique mechanisms and usually entail the events
mentioned below [11,79]:
1. Implantation of the desired biomolecule.
2. Blockage of the un-reacted sites.
3. Determination of the target biomolecule.
A chemical or biological reaction can be transduced into an electrical response by several forms of
electrochemical techniques, i.e., using voltammetry, potentiometry, impedimetry, conductometry or/and
amperometry. However, conductometric and potentiometric techniques are not yet actively employed
in developing electrochemical GQD sensors, due to their several limitations such as low-sensitivity,
less-stability, less-specificity and inaccuracy [254]. Therefore, in this section, we discuss the other three
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techniques in detail. Figure 15 shows the corresponding plots for voltammetric, amperometric and
impedimetric measurements, which are briefly explained in the ensuing sections.Sensors 2020, 20, x FOR PEER REVIEW 30 of 70 
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Figure 15. (A) Cyclic voltammetry (CV): potential vs. current profile with reference to a GQD-implanted
electrode surfac , wher its electroch mical response changes ac ording to the specific bio-recognition
event. (B) Square wave voltamm try (SWV): pot ntial vs. time profile, wher t: time required for each
pulse, f: frequency of each pulse, E1 and E2: initial and final pulse, respectively. (C) Target biomolecule
detection by GQD-coated electrode based on SWV, where the current changes in direct correlation with
an occupancy of a specific receptor. (D) Ideal curves observed with amperometric measurements for
varied concentrations of target biomolecules. (E) Electron impedance spectroscopy (EIS): variation in
impedance due to the modification of electrode surface and subsequent introduction of a target analyte
(i.e., Nyquist plot). Adapted from Mansuriya and Altintas [79].
3.1. Voltammetric GQD-Sensors
Voltammetric sensors employ the applied potential (E) to the surface of an electrode and
monitor the generated flow of current (i), where the amount of electroactive species is varied
with respect to tim through redox reaction. The ben fits of voltammetric tec niques reside in
their marvelous sensitivity, quick analysis, oncurrent de ection of different analytes, generation of
different potential waveforms, small current measur e ts a d determin tion of kinetic parameters.
Voltammetric biosensing methods can be based on polarographic, stripping voltammetric, linear scan
or sweep voltammetric, differential pulse voltammetric (DPV), normal pulse voltammetric (NPV) or
CV measurements [255–259].
While controlling the current in case of CV, the application of potential at a WE is swerved both
ways, i.e., reverse as well as forward (Figure 15A). Based on the desired analytical measurements, a
partial cycle, an entire cycle, or multiple cycles can be conducted [257]. In the case of NPV, the current
is computed after very pulse. Generally, each pulse endures for about 1 to 100 milliseconds nd the
interval between each pulses s 0.1 to 5 s [255,256]. DPV is more or les similar to NPV which also
involves a tential scan with a series of pulses. On the ot er hand, it is also distinguishable, because
each potential pulse is well defined in case of DPV and they are of small amplitude (10 to 100 mV).
Here, the current is computed two times for every pulse i.e., initially as well as finally [255,256].
The SWV excitation response constitutes a defined symmetry like a ‘staircase pattern’ (Figure 15B).
SWV is a widely used method, because its advantages lie in providing excellent sensitivity and
increased signal/noise ratio [258,259]. Moreover, the typical SWV peak right from the electrode
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functionalization to the target detection is displayed in Figure 15C. The advantages of pulse strategies
are that the decay rates are different, where the faradic current is too high as compared to the capacitive
current. This faradaic/capacitative current ratio leads to the achievement of an LOD, which makes
such techniques eligible for biosensing wide range of biomolecules [260]. Moreover, SWV and pulse
methods are reported to be more extensively employed than other techniques for the analytical
purposes [261,262].
Ensafi et al. fabricated a MIP sensor for quantifying metronidazole (MNZ) [263]. Initially, MIPs
were deposited on GQDs that were produced by the sol–gel–sol method. Thereafter, they were
cast on GCE functionalized with graphene nanoplatelets (GNPs). Due to the combined additive
effect of GNPs and MIPs@GQDs, the sensor showed noticeably improved electro-catalytic activity.
The electrochemical characterization of the modified GCE was successfully achieved by CV, DPV and
EIS techniques. This MIP-based electrochemical sensor could display two distinct linear ranges in
human blood plasma, i.e., from 0.005 to 0.75 µmol L−1 and 0.75 to 10.0 µmol L−1, and could offer a
lower quantification limit of 0.52 nmol L−1 for MNZ.
Hatamluyi and Es’haghi developed a MIP based electrochemical sensor to identify
6-mercaptopurine (6-MP) [264]. Herein, QDs exhibiting ZnO core covered on a shell of graphene
(i.e., ZnO@GQDs) were prepared, which were then implanted on the pencil graphite electrode (PGE)
grafted with a sol–gel binder and electro-polymerized with polypyrrole (PPy). The as-prepared GQDs
were characterized by energy dispersive X-ray (EDX), FE-SEM, FT-IR and XRD, while the sensor
surface had been characterized via CV and EIS. By using DPV, the electrochemical detection of 6-MP
could be possible in a broad linear range of 0.01 to 700.0 µM, with an LOD of 5.72 nM.
Yola and Atar constructed a MIP-based sensor for analyzing the serotonin (SER) levels in urine [265].
Herein, GQDs were fused with 2D hexagonal boron nitride (2D-hBN) nanosheets, incorporated to the
GCE surface and characterized by using TEM, XRD, CV, EIS, SEM, and X-ray photoelectron spectroscopy
(XPS). This MIP-based voltammetric sensor could sense SER from 1.0 pM to 10 nM. Moreover, this
sensor attained an LOD of 0.2 pM with high specificity for SER against several interfering compounds
like norepinephrine, dopamine and tryptophan. In 2019, Roushani et al. also established a MIP-based
sensor, but to check the sotalol (SOT) level in human blood serum as well as in pharmaceutical
tablets [266]. This sensor preparation involved the functionalization of SPCE with thiol doped GQDs
(GQD–SH) and AuNPs, where the modified sensor could quantify SOT in the linear calibration range
from 0.1 to 250 µM, with an LOD of 0.035 µM. Having acted as a sublayer in the nanocomposite mixture,
GQD–SH offered a large surface area for the further sequential immobilization of SPCE. Moreover,
AuNPs were implanted on to the SH groups of GQDs via an Au–S bond formation, resulting in the
increased electronic transfer rate, accelerated electrochemical signal response, as well as enhanced
adsorption of the SOT on SPCE.
An electrochemical DNA sensor was introduced by using peroxidase-like magnetic ZnFe2O4–and
GQDs hybrid nanomaterial [267]. This hybrid nanomaterial was prepared using a photo-Fenton reaction
that was employed as an enzyme-mimicking label and also as a carrier for labeling complementary
ssDNA. The modification of ZnFe2O4/GQDs/GCE was subsequently accomplished by a self-assembly
approach between aminated graphene and Pd nanowires, which could accelerate the electron transfer
efficacy and immobilize a large amount of capture ssDNA. In the study, thionine was chosen as an
electron mediator and, with the assistance of an enhanced electro-catalytic performance exhibited by
ZnFe2O4/GQDs, a large current was generated to reduce H2O2 for signal amplification. This sensor
could show a remarkable linear range from 1× 10−16 to 5× 10−9 M of target DNA, with the detection limit
of 6.2× 10−17 M. Joshi and Waghmode used GQDs for the sensitive detection of p16, a tumor-suppressor
gene causing pancreatic cancer [268]. In this work, an on-chip sensing system was exploited for p16
quantification through various electrochemical methods like DPV and EIS and were characterized by
employing several other techniques such as TEM, SEM and UV–Vis spectroscopy to develop a facile
DNA hybridization sensor (Figure 16) for the early diagnosis of pancreatic cancer, which possessed an
LOD of 0.10 pM.
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Such a sensing platform could deliver a quantification limit down to 0.1 µM for topotecan through DPV
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A two-step biomolecule-mediated self-assembly approach to establish ternary GQD-peptide
nanofibers (PNF)-GO nanohybrid material was reported for sensing H2O2 [272]. At first, PNFs were
used as templates to construct the N-GQDs nanowires by employing a one-step self-assembly technique
and then, binary GQD-PNF nanohybrids were pro uced, which were assisted by GO nanosheets to form
2D ternary GQD-PNF-GO anohybrid material. The principle b hind the pi–pi interacti n occurring
betwe n the materials residing within 2D ternary GQD-PNF-GO nanohybrids was examined by TEM
and atomic force microscopy (AFM). This electrochemical H2O2-sensor could perform well in a dynamic
linear range from 10 µM to 7.2 mM, with an LOD of 0.055 × µM. Also in 2017, an electrochemical sensor
was presented for testing H2Q in environmental water samples [273]. The sensor was hybridized with
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metal oxide and GQDs on the basis of their electrochemical features. Herein, Co3O4-histidine-modified
GQDs were synthesized to generate Co-HiS-GQD conjugate, following their thermal annealing at
350 ◦C in air to obtain Co3O4-HiS-GQD. The resulting hybrid nanomaterial could provide a 3D structure
enriched with porous architecture. On graphene sheets, the development of Co3O4 behaved in a
similar fashion as that of the electrochemical contacts between Co3O4 and HiS-GQDs, which facilitated
a rapid electron and energy transfer between HiS-GQDs and Co3O4 within the hybrid nanomaterial.
Using DPV, the voltammetric peak current of H2Q revealed an increased linear relationship (i.e., from
2 × 10−9 to 8 × 10−4 M). The authors reported an LOD value of 8.2 × 10−10 M for H2Q.
In a work based on the electrochemical detection of L-cysteine, a polypyrrole (PPy) and Prussian
Blue (PB)/GQD nanomaterial was incorporated to modify a graphite felt (GF) electrode [274]. The GQDs
were synthesized by ultrasonication via a carbonization reaction of citric acid and grafted on the
GF surface that induced the synthesis of PB through a simultaneous oxidation and reduction
between [Fe(CN)6]3− and Fe3+. The electropolymerized PPy layer led to the enhanced stability
of a PPy/PB/GQDs@GF electrode, which was then characterized by infrared (IR), XRD, TEM, SEM and
electrochemical methods. The sensor could efficiently oxidize L-cysteine by virtue of its electro-catalytic
performance, ranging from 0.2 µmol L−1 to 1.0 mmol L−1, with an LOD of 0.15 µmol L−1 and showed a
quite negligible response to the other interfering compounds.
In 2018, Lu et al. fabricated a voltammetric sensing device comprising nanochannel-confined GQDs
to distinguish and quantify several metal ions (i.e., Hg2+, Cu2+ and Cd2+ ions) from environmental
and food samples as well as dopamine in human blood [275]. In this research, a vertically-oriented
mesoporous silica-nanochannel film (VMSF) was terminated on the electrode surface, providing
an excellent antifouling and anti-interfering characteristics to the electrode by steric exclusion and
electrostatic repulsion mechanisms. The as-prepared GQDs, rendering multi-functionality, were
confined in the nanochannels of VMSF via electrophoresis, and served as the signal amplifier as well
as the recognition element. As illustrated in Figure 17, this versatile electrochemical method could
quantify Hg2+, Cu2+ and Cd2+ ions with the respective LOD values of 9.8 pM, 8.3 pM, and 4.3 nM.
Moreover, it can also detect dopamine with a minimum concentration of 120 nM.
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film) modified el ctrode via electrophoresis. (B) Quantification of Cu2 , g2+ and Cd2+ ions as well as
dopamine. Adapted from Lu et al. [275].
Lie et al. constructed an lectrochemi al sensor for dopamine [276]. The study aimed to immobilize
GQDs on GCE via a covalent self-assembled approach, which was subsequently examined by several
characterization techniques like TEM, FT-IR, AFM, CV, EIS and DPV. This electrochemical GQD-sensor
could respond to dopamine in a linear range from 1 µM to 0.15 mM, with the quantification limit of
115 nM. Besides, the authors stated that this sensor could be highly specific to dopamine, giving a
negligible response to the other potent interfering molecules such as ascorbic and uric acids.
Sensors 2020, 20, 1072 34 of 71
An electrochemical agricultural analysis of L-DOPA was examined by functionalizing the surface of
GCE with GQDs, magnetic NPs and multi-walled carbon nanotubes (MWCNTs) [277]. Here, the GQDs
were prepared by pyrolyzing citric acid and all these nanomaterials underwent characterization by
TEM, XRD and FT-IR methods. With the help of DPV, this biosensor could deliver sensitive and
selective identification of L-DOPA, ranging from 3.0 to 400 µmol L−1, with an LOD of 14.3 nmol
L−1. In the same year, an electrochemical experiment was carried out to analyze a drug, doxorubicin
hydrochloride (DOX-HCl), where the GQDs were synthesized by a bottom-up approach and then,
tightly absorbed on the GCE surface [278]. The CV profile suggested that the GQD-coated GCE could
conspicuously increase the electro-catalytic behavior toward the oxidation of DOX-HCl, while DPV
was also employed for confirming the DOX-HCl response that ranged in a broad linear spectrum from
0.018 to 3.6 µM, with an LOD value of 0.016 µM in human plasma.
Selecting GQDs and AgNPs as GCE modifiers, an electrochemical concept for the concurrent
oxidation of guanine and adenine was studied, where the sensing platform could not only just quantify
them, but also exhibited an ability to discriminate these purine bases [279]. The GCE functionalized
with GQDs/AgNPs could reveal a decrement in anodic peak overpotentials and an increment in anodic
peak currents. At the same time, the modified GCE surface was enlarged nearly 22 fold as compared to
the bare surface, suggesting the significance of using these nanomaterials. The linear calibration plots
for guanine and adenine were found in the range from 0.015 to 430 µM and 0.015 to 390 µM, respectively.
Moreover, the corresponding LOD values were computed as 10 nM and 12 nM, respectively.
Hasanpour and coworkers casted a voltammetric sensor for evaluating dobutamine (DB) levels
in human serum, which is a catecholamine drug to treat coronary heart disease and cardiogenic
shock [280]. Here, N–GQDs were sourced from citric acid and urea and then, nickel manganese
ilmenite-type (NiMnO3) was synthesized in the presence of N–GQDs using a one-step hydrothermal
route. This nano-hybrid material was characterized by XRD, SEM as well as FT-IR and functionalized
on CPE that enabled the electron transfer rate as well as the catalytic activity for electro-oxidation of
DB. The oxidation aspect of DB was approved by CV, where a linear response of DB concentration
ranged between 0.08–40.0 µM, with an LOD of 0.02 µM.
By taking riboflavin as a redox probe, Valipour et al. explored the functions of thiolated
graphene quantum dots (GQD-SH) as well as AgNPs as electrode-enhancing agents for determining
hepatitis C virus (HCV) in a spiked human serum [281]. AgNPs were loaded on GQDs–SH through
the Ag-S bond and subsequently, anti-HCV antibodies were immobilized on the GCE. Using DPV,
the specific immune-recognition was investigated through the decrease in oxidation signal response
of the redox probe. This immunosensing platform displayed a broad linear range (0.05 pg mL−1 to
60 ng mL−1) with an LOD of 3 fg mL−1. Later on, in 2019, they fabricated a facile and reasonable
voltammetric antibody-sensor to selectively and accurately determine human chorionic gonadotropin
(HCG) [61]. AuNPs and N,S–GQDs were embedded stepwise onto the surface of SPCE (Figure 18).
The as-functionalized SPCE enhanced the antibody capturing as well as amplified the signal for the
sensitive analysis of HCG. To study the electrochemical characterization of SPCE, the electrode was
then examined by ESI as well as CV methods. At the same time, DPV could determine HCG over
0.1–125 pg mL−1 concentrations, with an LOD of 12.5 fg mL−1. Furthermore, the reproducibility of
the as-developed sensor was studied by carrying out the intra- and inter-assay precisions, which
revealed that the nanocomposite functionalized SPCE retained good reproducibility as well as a broad
potential window.
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In 2018, Cai et al. reported an electrochemical sensing technique for calycosin, a biomarker
responsible for inflammation, diabetic cognitive impairment and cardiac diseases [282]. In this work,
polyaniline functionalized GQDs were produced by following an in situ polymerization. Their
characterization was carried out by FT-IR and Raman spectroscopy, whereas the modified GCE was
characterized by TEM and SEM. Owing to the CV and EIS results, the as-functionalized GCE could
boost up the electron transferability. The DPV method revealed a broad linear regression function for
calycosin, ranging from 11 to 352 µmol L−1, with a minimum detection capability of 9.8 µmol L−1.
In 2018, Hasanzadeh and coworkers developed a ternary signal amplification approach for
demonstrating a voltammetric antibody-sensor to sensitively detect the p53 gene [283]. The experiment
involved the immobilization of biotinylated p53 antibody onto a biocompatible and green
nanocomposite layer comprising AuNPs/GQDs and poly L-cysteine (P-Cys) as amplifying components
and polymeric matrix, respectively. An amalgamation of such nanomaterials enhanced the lateral
surface of an Au-electrode for the effective immobilization of anti-p53 bio-receptors. Such a sensing
system could exhibit a wide linearity of 0.0488–12.5 pM with an LOD of 23.4 fM. As shown in Figure 19,
these researchers also designed an immunosensor for accurately recognizing CA 15-3, a tumor marker
responsible for breast cancer [284].The electrode was functionalized by thiolated–GQDs, AuNPs and
cysteamine (CysA). Consecutively, GQDs/AuNPs/CysA system offered abundant sites for capturing CA
15-3 molecules as well as the stability. The sensor could respond in a linear fashion of 0.15–125 U mL−1,
with an LOD of 0.11 U mL−1.
A sandwich-type electrochemical sensor was designed for determining PSA in human blood
sample [285]. The sensor construction process involved graphene sheets modified with GQDs for
capturing anti-PSA molecules upon GCE. The electrochemical sensing of PSA could be achieved by
SWV and offered a broad linear range from 0.005 to 10 ng mL−1 with an LOD of 3 pg mL−1, which was
achieved because of the enhanced anti-PSA immobilization onto GCE as well as excellent electron
transferability of GQDs.
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In 2018, Mollarasouli and the group designed a voltammetric antibody-sensor to quantify a
tyrosine kinase bio-receptor, i.e., AXL [286]. This protein is one of the major biomarkers responsible
for the cardiac-arrest [287]. In this approach, 2-aminobenzyl amine (2-ABA) was used to modify
GQDs@SPCE through electro-polymerization. To assure the adherence of GQDs onto the electrode
surface, the functionalized SPCE was then incubated at 120 ◦C for about 60 min. Thereafter, the AXL
antibodies were incubated on the electrode surface for 90 min. Using DPV, the target analyte was
determined in a dynamic concentration range from 1.7 to 1000 pg mL−1 with the detection limit of
0.5 pg mL−1.
Tufa and colleagues proposed a sandwich-immunoassay sensor to quantify Mycobacterium
tuberculosis antigen (i.e., CFP-10) using AuNPs and GQD-embedded Fe3O4(core)@Ag(shell) nanocomplex
as signal amplification labels and GCE enhancer, respectively [288]. This immunosensor exhibited
an additive effect due to the multifarious role played by the nanomaterials residing within the
nanocomplex, i.e., Ag accelerated the electron transferability, GQDs increased the surface area for
the effective immobilization of anti-CFP-10 antibodies, and Fe3O4 enlarged the surface/volume ratio.
The CFP-10 antigens were determined using DPV that offered a broad linear response from 5.0 ng mL−1
to 500 µg mL−1, with 0.33 ng mL−1 being the quantification limit.
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An avian leukosis virus subgroup J (ALVs-J) was quantified by employing Fe3O4-fused GQDs 
and apoferritin-implanted Cu (apoferritin-Cu) NPs via a signal amplification strategy [289]. In the 
study, the researchers used GQDs to effectively immobilize anti-ALVs-J. On the other hand, 
apoferritin-Cu NPs were conjoined with the GQDs/Fe3O4 hybrid material. Subsequently, to release 
Cu from the apoferritin cavity, the immunochip was dipped in an acidic medium. The detection of 
ALVs-J antigen was accomplished by this biosensor in a linear range of 102–105 TCID50 mL‒1, where 
an LOD of 115 TCID50 mL‒1 was reported. 
Bhatnagar and the team engineered a voltammetric sensor for quantifying cTnI [290]. In this 
work, the electrode surface was initially laminated with 4-aminothiophenol (4-ATP), where the 
resultant NH2 groups were then covalently attached to the COOH groups of GQD through 
carbodiimide coupling chemistry. Moreover, the sensitivity of the sensor was improved by 
polyamidoamine (PAMAM) that was fused with GQD. Serving as the electrode enhancers, these 
nanomaterials could give a larger surface area to mount the antibodies. Subsequently, the activated 
cTnI monoclonal antibodies were immobilized on PAMAM dendrimer for probing cTnI antigens 
(Figure 20). The immunoreaction was examined with the help of DPV and CV, attaining an LOD of 
20 fg mL‒1 over a wide cTnI concentration range from 10‒6 to 10 ng mL‒1. Very recently, 
Lakshmanakumar et al. designed a model for cTnI biomarker determination [291]. In this work, acetic 
acid functionalized GQDs (fGQDs) were used as an interface for cTnI, where the interaction between 
cTnI and fGQDs was investigated by CV as well as amperometry. The carbodiimide coupling reaction 
between the NH group of cTnI and the functionalized COOH group on GQDs was responsible for 
the identification of cTnI over a linear range of 0.17 to 3 ng mL−1 and an LOD of 0.02 ng mL−1. Besides, 
Table 4 features some critical aspects associated with several other recently reported GQD-sensors 
based on voltammetry. 
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An avian leukosis virus subgroup J (ALVs-J) was quantified by employing Fe3O4-fused GQDs and
apoferritin-implanted Cu (apoferritin-Cu) NPs via a signal amplification strategy [289]. In the study,
the researchers used GQDs to effectively immobilize anti-ALVs-J. On the other hand, apoferritin-Cu
NPs were conjoined with the GQDs/Fe3O4 hybrid material. Subsequently, to release Cu from the
apoferritin cavity, the immunochip was dipped in an acidic medium. The detection of ALVs-J antigen
was accomplished by this biosensor in a linear range of 102–105 TCID50 mL−1, where an LOD of
115 TCID50 mL−1 was reported.
Bhatnagar and the team engineered a voltammetric sensor for quantifying cTnI [290]. In this work,
the electrode surface was initially laminated with 4-aminothiophenol (4-ATP), where the resultant NH2
groups were then covalently attached to the COOH groups of GQD through carbodiimide coupling
chemistry. Moreover, the sensitivity of the sensor was improved by polyamidoamine (PAMAM) that
was fused with GQD. Serving as the electrode enhancers, these nanomaterials could give a larger
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surface area to mount the antibodies. Subsequently, the activated cTnI monoclonal antibodies were
immobilized on PAMAM dendrimer for probing cTnI antigens (Figure 20). The immunoreaction was
examined with the help of DPV and CV, attaining an LOD of 20 fg mL−1 over a wide cTnI concentration
range from 10−6 to 10 ng mL−1. Very recently, Lakshmanakumar et al. designed a model for cTnI
biomarker determination [291]. In this work, acetic acid functionalized GQDs (fGQDs) were used
as an interface for cTnI, where the interaction between cTnI and fGQDs was investigated by CV as
well as amperometry. The carbodiimide coupling reaction between the NH group of cTnI and the
functionalized COOH group on GQDs was responsible for the identification of cTnI over a linear
range of 0.17 to 3 ng mL−1 and an LOD of 0.02 ng mL−1. Besides, Table 4 features some critical aspects
associated with several other recently reported GQD-sensors based on voltammetry.
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Table 4. Various GQD-based voltammetric sensors reported (2017 onwards) for biomedical applications.
Electrode Nanomaterials ReceptorType Receptor
Target
Analyte
Detection
Technique(s) Specimen Linear Range
Detection
Limit Reference
GCE GQDs Enzyme Laccase EP CV Pharmaceuticals 1–120 µM 83 nM [292]
GCE N–GQDs Oligosaccharide β-CD Cholesterol DPV Buffer, humanserum 0.5–100 nM 80 nM [293]
GCE GQDs Nucleic acid DNA probe HBV CV; DPV Human serum 10 –500 nM 1 nM [294]
GCE C3N4NTs@GQDs MIP
CHL-imprinted
polymer CHL SWV Waste water 0.01–1 nM 2 pM [295]
SPGE PAMAM/GQDs/AuNPs@MWCNTs Antibody Anti-tTG tTG CV; DPV
Buffer; human
serum 20 fg mL
−1–2 µg mL−1 20 fg mL−1 [76]
GCE Ru(core)@Au(shell) MIP
PEA-imprinted
polymer PEA CV; DPV Urine 1 pM–1 nM 0.2 pM [296]
GCE AuPdNWs/D-GQDs–GMA Nucleic acid DNA probe Ara h1 DPV Peanut milk 1 × 10−22–1 × 10−17 M 4 × 10−23 M [297]
GCE GQDs/PdNPs MIP CIT-imprintedpolymer CIT CV; DPV Chicken egg 1–5 nM 0.2 nM [298]
GCE GQDs Enzyme Uric oxidase UA CV Human serum 1–800 µM 0.3 µM [299]
SPCE GQDs implantedwith N-ABA MIP
Ifsosfamide-imprinted
polymer IFO DPV
Aq. Solution;
Blood plasma;
Urine;
Pharmaceuticals
0.25–121 ng mL−1
0.31–116 ng mL−1
0.28–110 ng mL−1
0.32–109 ng mL−1
0.08 ng mL−1
0.11 ng mL−1
0.10 ng mL−1
0.10 ng mL−1
[300]
GCE NH2–GQDs/PBP(electroactive label)
Nucleic acid ss-ds-DNA probes microRNA-25 DPV
Spiked human
serum 0.3 nM–1 µM 95 pM [301]
GCE GQDs Enzyme Glucose oxidase Glucose CV; DPV Buffer 10 µM–3 mM 1.35 µM [16]
GCE GQDS/hNiNs MIP BPS-imprintedpolymer BPS DPV
Mineral water;
extracted plastic
solution
0.1–50 µM 0.03 µM [302]
Abbreviations: β-CD: β-Cyclodextrin; Ara h1: Peanut allergen; Aq.: Aqueous; AuNPs: Gold nanoparticles; BPS: Bisphenol S; C3N4NTs: Carbon nitride nanotubes; CHL: Chlorpyrifos; CIT:
Citrinin; D-GQDs: Dodecylamine-GQDs; DNA: Deoxyribonucleic acid; EP: Epinephrine; GMA: graphene micro-aerogel; HBV: Hepatitis-B virus; hNiNs: Hollow nickel nanospheres;
IFO: Ifsosfamide; MIP: Molecularly imprinted polymer; MWCNTs: Multi-walled carbon nanotubes; N-ABA: N-Acryloyl-4-aminobenzamide; N–GQDs: Nitrogen-doped GQDs; NWs:
Nano-waxberries; PAMAM: Polyamidoamine; PBP: p-Biphenol Pd: Palladium; PEA: Phenyl-ethanolamine; Ru: Ruthenium; ss-ds-DNA: Single- and double-stranded DNA; SWV: Square
wave voltammetry; tTG: tissue transglutaminase; UA: Uric acid.
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3.2. Amperometric GQD Sensors
Amperometric sensors interpret the current flow generated at a constant voltage within the
electrochemical cell. These sensors work on the principle of specific molecular bio-recognition to form
a receptor-analyte complex. They can involve either a direct or indirect (i.e., non-labeled or labeled)
assay approach. The former case determines physical changes caused during the formation of the
receptor–analyte complex, while the latter case uses signal generating labels. It is worth noting that
indirect mode is generally selected over the direct amperometry owing to its versatility and higher
sensitivity [303]. These biosensors measure the potential applied between a RE and a WE to facilitate
the redox reaction by calculating the resultant current [240]. Therefore, the current produced during an
electrochemical reaction corresponds to the amount of signaling elements [304]. Figure 15D depicts the
ideal plot of amperometric sensor signals.
Hu and co-workers designed a facile amperometric RNA sensor for quantifying miRNA
by employing HRP-based catalysis [305]. This sensing system was fabricated by a ds-DNA.
Herein, ds-DNA was hybridized on Au-electrode via the use of capture DNA probe (i.e., thiolated
oligodeoxynucleotide), aminated indicator probe (NH2–DNA) as well as target DNA. Subsequently,
the activated carboxyl groups of GQDs were functionalized on NH2–DNA via a non-covalent interaction.
This HRP-modified sensor was able to catalyze the H2O2-mediated oxidation of TMB, guarded by a
color change of a solution from transparent to blue and led to an amplified electrochemical current
signal. Owing to the use of GQDs and enzyme catalysis, the as-prepared biosensor could sensitively
quantify miRNA-155 in the range of 1 fM–100 pM, with an LOD of 0.14 fM, which could be ascribed to
the good biocompatibility as well as greater surface/volume ratio offered by GQDs.
As portrayed in Figure 21, Mars et al. introduced a DNA-sensor for targeting APO e4 DNA in human
blood, which causes Alzheimer’s disease [306]. Herein, electrochemical as well as fluorescence-sensitive
curcumin and GQDs were electropolymerized on to an indium tin oxide (ITO)-coated electrode.
An amino-functionalized DNA probe was then covalently implanted by EDC-NHS coupling chemistry
to establish a complex consisting of hybridized DNA and curcumin. Amperometric measurements
indicated that this strategy can be used to determine APO e4 DNA in a linear calibration region of
20–400 × 10−12 g mL−1 and estimated an LOD of 0.48 × 10−12 g mL−1.
Sensors 2020, 20, x FOR PEER REVIEW 39 of 70 
 
3.2. Amperometric GQD Sensors 
Amperometric sensors interpret the current flow generated at a constant voltage within the 
electrochemical cell. Th se sensors work on the principle of specific molecular bio-recognition t  form 
a r ceptor- nalyte complex. They can involv  either a direct or indirect (i.e., non-lab led or lab led) 
assay approach. The former case d termines physical changes cause  during the formation of the 
r ceptor–analyte complex, while the latter case u es signal g nerating labels. It is worth noting that 
indirect mode is g nerally s lected over the direct amperometry owing to its versatility and higher 
sensitivity [ 03]. Th se biosensors measure the potenti l applied between a RE and a WE to facilitate 
th  redox reaction by alculating the resultant current [240]. The for , the current pro uced during 
an electro hemi al reaction corresponds t  the amount of signaling elements [304]. Figure 15D 
depicts the ideal plot of amperometric sensor signals. 
Hu and co-workers designed a facile a r tri   sor for quantifying miRNA by 
employing HRP-based catalysis [305]. This sensing system was fabricated by  ds-DNA. Herein, ds-
DNA was hybridized on Au-electrod  via the use of capture  probe (i.e., thiolated 
oligodeoxynucleotide), aminated indicator probe ( 2 ) as ell as target DNA. Subsequently, the 
activated carboxyl groups of  r  f cti li e  on NH2–DNA via a non-covalent interaction. 
This HRP-modified sensor was able to catalyze the H2O2-mediated oxidation of TMB, guarded by a 
c lor change of a solution from transparent to blue and led to an amplified electrochemical current 
signal. Owing to the use of GQDs and enzyme catalysis, the as-prepared biosensor could sensitively 
quantify miRNA-155 in the range of 1 fM–100 pM, with an LOD of 0.14 fM, which could be ascribed to 
the good bi compatibility as well as greater surface/volume ratio offered by GQDs. 
As portrayed in Figure 21, Mars et al. introduced a DNA-sensor for targeting APO e4 DNA in 
human blood, whic  causes Alzheimer’s disease [306]. Herein, lectrochemical as well as 
fluorescence-sensitive curcumin and GQDs were electropolymerized n to an indium tin oxide (ITO)-
coated electrode. An amino-function lized DNA probe was then covalently implanted by EDC-NHS 
coupling che istry to establish a complex consisting of hybridized DNA and curcumin. 
Amperometric measurements indicated that this strategy can be used to determine APO e4 DNA in 
a linear calibration region of 20–400 × 10−12 g mL−1 and estimated an LOD of 0.48 × 10−12 g mL−1. 
 
Figure 21. Set-up of an electrochemical and fluorescence based DNA-sensor for APO e4 DNA [306]. 
In 2017, a label-free electrochemical DNA-sensor for M.SssI activity determination was 
engineered, depending on the amplification of GQDs and an enzyme-catalyzed reaction [307]. The 
Figure 21. Set-up of an electrochemical and fluorescence based DNA-sensor for APO e4 DNA [306].
Sensors 2020, 20, 1072 40 of 71
In 2017, a label-free electrochemical DNA-sensor for M.SssI activity determination was engineered,
depending on the amplification of GQDs and an enzyme-catalyzed reaction [307]. The stepwise
fabrication of this sensor involved the hybridization of a capture DNA with auxiliary DNA to develop
a structure of ds-DNA, possessing a specific recognition sequence (5′-CCGG-3′) for both M.SssI and
restriction endonuclease, HpaII. The ds-DNA was methylated by M.SssI, which was unable to be
digested by HpaII, leading to the attachment of GQDs with this undigested ds-DNA that could
immobilize HRP via a non-covalent assembly. Such a sensing platform could catalyze H2O2-mediated
oxidation of TMP for an amplified electrochemical signal response. This DNA-sensor could monitor
the M.SssI activity in a wide range between 1 to 40 U mL−1, with an LOD of 0.3 U mL−1. Moreover,
this sensor was also applied to check an inhibitory effect of M.SssI for the screening and development
of drugs like procaine and epicatechin.
In 2018, Dourandish and Beitollahi synthesized GQDs by altering the carbonization degree
of citric acid, where they functionalized a graphite screen-printed electrode with these GQDs for
an amperometric determination of isoproterenol [308]. In contrast to the unmodified electrode,
the GQD-coated electrode caused an enhancement in signal response. The peak currents generated by
the GQD electrode for isoproterenol were analyzed by CV, DPV as well as chronoamperometry, which
exhibited a wide dynamic linear range from 1 to 900 µM, with an LOD value of 0.6 µM.
A sensitive non-enzymatic amperometric sensor was designed by Zhu et al. with long-term
stability, good reproducibility and anti-interference. This sensor was fabricated using GQDs, AuNPs
and polydopamine (PDA) as a catalyst, signal amplifying element and as an adhesive agent,
respectively [309]. The synergistic effect of Au-PDA-GQDs nanocomposite exhibited an excellent
electro-catalytic activity towards the reduction of H2O2. This biosensor based on Au-PDA-GQDs could
quickly sense H2O2 (<2 s), with quite a broad linear relationship, ranging from 0.1 to 20,000 µM and an
LOD of 5.8 nM.
Ju et al. developed an amperometric sensing strategy exploiting the use of N-GQDs, where
the surfactant-free AuNPs were grown on N-GQDs in order to create abundant adsorption
sites [310]. This hybrid nanocomposite was prepared by simply adding chloroauric acid
(HAuCl4·4H2O) to N-GQDs solution without mixing other surfactants and reductants. The resulting
non-surfactant-capped AuNPs could deliver naked catalytic surface with strong electro-catalytic
activity. This electrochemical sensor could detect hydrogen peroxide (H2O2) in human serum samples
and H2O2 liberated from human cervical cancer cells with an LOD of 0.12 µM and a linear response in
the range of 0.25−13327 µM.
Rezaei and Razmi used GQDs as an appropriate substrate for immobilizing an enzyme, GOx
on a carbon ceramic electrode (CCE), where the quasi-reversible redox peaks were generated [311].
The UV–vis PL spectroscopy, TEM, SEM, EIS and CV methods confirmed the successful construction
of the CCE, while amperometric measurements revealed the presence of glucose over the range of
5 to 1270 µM, with the quantification limit of 1.73 µM. An excellent performance of this biosensor
can be ascribed to the greater surface-to-volume ratio, porosity of GQD@CCE, good biocompatibility
of GQD and the numerous hydrophilic edges as well as the hydrophobic plane in GQD, which
facilitated the enzyme immobilization on CCE. In 2016, the same group investigated the impact of
electron transfer as well as the direct electrochemistry of hemoglobin on GQDs-chitosan nanocomposite
(Hb-GQDs-Chit) [312]. In this study, an amperometric sensor was constructed for detecting H2O2
in urine samples, which was characterized by TEM, PL, UV–Vis, XRD, CV and EIS techniques.
The biosensor realized the sensitive detection of H2O2 in a broad spectrum from 1.5 to 195 µM, with an
LOD of 0.68 µM. In the same year, Xi et al. also developed an amperometric biosensor for H2O2 for
an early diagnosis of cancer, where they used carbon based hollow-structured nanospheres (HNSs)
grafted with Pd NPs garnished N–GQDs as the dual signal-amplifying nanoprobes [313]. The fusion
of these nanomaterials promoted the electron transfer as well as electro-catalytic activity for H2O2,
due to the electrochemical reduction of H2O2 at 0 V, which could hinder the redox potential of several
other electroactive agents in biological matrices by efficiently ignoring the interference signal response.
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The authors inferred that this biosensor could trace the minimum H2O2 concentrations of 20 nM,
within just 2 s with high sensitivity, selectivity, stability and reproducibility.
Yang and coworkers introduced a label-free sensing strategy, relying on antibody receptors [78].
This immunosensor was fabricated by modifying GCE with Au, PtPd and N-GQDs for the selective
identification of CEA. Using a self-assembly process, PtPd/N-GQDs/Au hybrid was synthesized
(Figure 22) through covalent interaction. The combined additive features provided by nanomaterials
residing in the resultant hybrid material include larger surface area, enhanced electron transferability,
excellent biocompatibility and ability to catalyze H2O2. Hence, these nanocomposites, acting as the
signaling species, were employed for signal transduction as well as to effectively conjugate bioreceptors.
PtPd/N-GQDs/Au was used as a transducer to efficiently conjugate the capture antibodies and to act as
a signal amplification system. The as-studied sensing system was highly specific for CEA because it
could generate a negligible response for various interfering agents such as BSA, IgG, PSA and hepatitis
B surface antigen (HBS). It was reported that this sensing tool could be capable of quantifying CEA
down to 2 fg mL−1 with a linear regression function ranging from 5 fg mL−1 to 50 ng mL−1.
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Muthurasu and Ganesh quantified H2O2 with the help of an enzyme-based amperometric sensor
using GQDs that were prepared by modifying Hummer’s method [314]. In the study, HRP was
conjoined with the GQDs via an acid–amine coupling to form a peptide-amide bond. The activity
of HRP was determined through its drop-casting on GQDs-modified GCE, where the sensor could
perform well for H2O2 from 100 µM to 1.3 mM, with an LOD of 531 nM. On the other side, Jiang et
al. developed an enzyme-free approach for H2O2 sensing by functionalizing a gold electrode with
GQDs, silver nanocubes and chitosan [315]. The Chit–GQDs/AgNCs electrode displayed an excellent
electro-catalytic activity to reduce H2O2, revealing the amperometric measurements in a dynamic
linear range of 10 µM to 7.8 mM, with an LOD of 0.15 µM.
Roushani and Abdi reported an electrochemical platform for sensing persulfate (S2O8−2) [316].
The sensor was developed by modifying GCE with GQDs and riboflavin, which was characterized
by TEM, UV–vis and PL spectroscopy. The GQDs/riboflavin/GCE showed high stability and a wide
array of pH (i.e., from 1 to 10) for redox couples having surface-confining features. Moreover, this
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GQD-sensor could readily catalyze the S2O8−2 reduction reaction and reflected an amperometric
response of S2O8−2 over a wide linear range (i.e., from 1 µM to 1 mM), with an LOD of 0.2 µM.
In 2019, Altintas and Savas fabricated a novel label-free immunosensing platform for Yersinia
enterecolitica (Y. enterecolitica) [67]. The sensor set-up was commenced through the functionalization of
the Au electrode by GQDs, due to their excellent catalytic behavior to reduce H2O2. Herein, the specific
antibodies were immobilized via the blockage of non-reacted COOH groups on an Au electrode,
using both ethanolamine (EA) as well as BSA, as outlined in Figure 23. Thereafter, Y. enterecolitica
was determined by amperometry, which depended on the inactivation of GQDs’ electro-conductivity
due to the resultant immunoreaction. Correspondingly, elevated concentrations of Y. enterecolitica
suppressed the amperometric signal response. This articulately formulated sensing device could
demonstrate a broad linear relationship even in complex media such as human serum and milk in the
range of 1-6.23 × 108 cfu mL−1, with an LOD of 30 cfu mL−1 and 5 cfu mL−1 in human serum and milk,
respectively. Importantly, the matrix effect could not impact the sensing mechanism considerably, since
the investigational array and the LOD values attained in a phosphate buffer saline were quite identical
to that in biological samples (i.e., the sensor exhibited an LOD of 1 cfu mL−1 with amplified signal
response in buffer as compared to the complex media). Moreover, the authors also stated that this
antibody sensor is highly specific to Y. enterecolitica, as it showed negligible response against various
other interfering bacteria such as Yersinia pestis, E. coli, B. anthracis and Salmonella enteritidis, suggesting
the multifarious as well as an attractive tendency of GQD-immunosensors.
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Figure 23. Schematic illustration of a GQD-based antibody sensor for Y. enterecolitica quantification [67].
Various researches on interleukin-13 receptor α2 (IL13Rα2) have trotted out that its overexpression
can form several cancerous cells including AIDS-associated Kaposi’s sarcoma, colorectal, glioma as well
as squamous cancer of the neck and head [317]. In 2019, Serafín et al. demonstrated an amperometric
antibody sensor to quantify IL-13Rα2 which entails the implantation of streptavidin-functionalized
SPCEs with biotinylated-specific capture antibody via their treatment with p-amino benzoic
acid (p-ABA) and further surface modification through carbodiimide-coupling chemistry [318].
A nanocomposite consisting GQDs and MWCNTs was chosen as an HRP mimic and a nanocarriers of
the detector antibody, respectively. The involvement of such a nanocomposite enhanced the sensitivity
remarkably owing to the GQDs’ peroxidase-mimicking catalytic performance. The electrochemical
measurements for IL-13Rα2 through hydroquinone (HQ)/H2O2 assembly could show a quantification
limit of 0.8 ng mL−1 over a broad linear concentration range (i.e., 2.7 to 100 ng mL−1). Such a
sensing system can be clinically applied to selectively and rapidly detect IL-13Rα2 for the diagnosis of
colorectal cancer. The same team has demonstrated a dual amperometric bio-assay for the concurrent
determination of CDH-17 and IL-13Rα2, tumor markers responsible for colorectal and breast cancers,
respectively [81]. Within this study, screen-printed dual carbon electrode (SPdCE) was assembled with
GQDs/MWCNTs for establishing the sandwich immunoassay mode. Thereafter, the fabrication process
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of SPdCE as well as the detection technique were conducted in an identical manner as described in their
aforementioned study. This immunoassay could provide the selective quantification of both tumor
markers (i.e., CDH-17 and IL-13sRα2) with respective LOD values of 0.03 ng mL−1 and 1.4 ng mL−1.
In 2018, a GCE-based label-free antibody sensor was proposed to determine hepatitis B surface
antigen (HBsAg) [250]. As shown in Figure 24, the study aimed to implant surfactant-less AuPdCu
ternary NPs onto N-GQDs (N-GQDs/AuPdCu), which offered excellent electro-conductivity and
strong catalytic performance for H2O2 reduction. Additionally, polyethylenimine (PEI)-decorated
electroactive polymer nanospheres (PS) was used as a transducer for delivering N-GQDs/AuPdCu
as well as for subsequently immobilizing the bioreceptors (i.e., anti-HBs antibodies). The stepwise
fabrication of the electrode surface was characterized by EIS measurements, whereas amperometric
detection of HBsAg revealed the linear relationship in the range of 10 fg mL−1–50 ng mL−1 and attained
an LOD of 3 fg mL−1.
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PS. Adapted from Mansuriya and Altintas [79].
On the basis of a double-signal amplification approach, Malekzad and co-workers successfully
quantified PSA, using mediator-free multilayer amperometric antibody sensor [319]. Herein, anti-PSA
antibody was incubated with a biocompatible nanocomposite film of GQDS/AuNPs and poly
L-cysteine (P-Cys) as dual-signal amplification elements and as a conductive matrix, respectively.
This methodology was employed for developing a novel transduction platform on an Au surface that
improved the surface of electrode for capturing abundant antibodies. Moreover, AuNPs were prepared
by a soft template synthesis technique that attained a compact morphology. The as-functionalized
electrode surface was then characterized by energy-dispersive spectroscopy (EDX) and high-resolution
FE-SEM. The calibration curve for PSA concentration was linearly co-related in the range of 2–9 pg mL−1,
with an LOD of 1.8 pg mL−1.
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3.3. Impedimetric GQD Sensors
Numerous research works have been devoted to the conception of impedimetric or capacitive
biosensors. EIS is acutely used to characterize the functionalized sensor surface, to examine kinetic
interactions among various biological molecules like proteins, DNAs, receptors, antigens, antibodies,
etc., and to establish label-free sensors [21,320]. The impedance measurements can be non-faradic or
faradic; in other words, in the absence or presence of a redox probe. The latter measurements determine
biochemical reactions occurring at the surface of a functionalized electrode through the interpretation
of interfacial electron transfer resistance [320,321]. EIS converts an electrochemical signal response into
a minute amplitude sinusoidal voltage response with respect to the frequency. As a result, current
sine wave is generated, which changes with respect to the voltage wave and time (i.e., phase shift).
This current to voltage ratio (V(t)/I(t)) generates an impedance (Z) [322,323]. For gaining the information
of bio-recognition events taking place at the interface, a Randles equivalent circuit (i.e., simulated circuit)
is generally employed for the determination of the mass-transfer resistance (Rmt), the charge-transfer
resistance (Rct), electrolyte resistance (Rel), double-layer capacitance (Cdl) and Warburg impedance
(W) [324]. The Bode and Nyquist plots retrieve the EIS information [79]. In the Bode plot, frequency is
plotted against the overall impedance (|Z|). In the case of the Nyquist plot, the real part of impedance (Z’)
versus the imaginary part of impedance (−Z”) is plotted (Figure 15E) [325]. The impedimetric sensors
are efficient due to their easy instrumentation, lucrative electrode bulk manufacturing, miniaturization
ability, and remote control of the grafted sensors [322].
Bhardwaj et al. reported a label-free impedimetric-sensing strategy using GQDs to detect aflatoxin
B1 (AFB1), a food toxin [326]. GQDs were chemically prepared on the basis of Hummer’s method, as
depicted in Figure 25 [327]. The sensor assembly was terminated by the electrophoretic deposition (EPD)
of hydrothermally prepared GQDs on to an ITO-coupled glass electrode, following an immobilization
of monoclonal AFB1-antibodies using EDC-NHS chemistry. The excellent electro-conductivity and
increased surface area of the GQD sensor led to the detection of AFB1-contaminated maize samples in
a broad linear range from 0.1 to 2.0 ng mL−1, with an LOD of 0.03 ng mL−1. Moreover, the researchers
declared that this sensing platform could last its activity almost up to 7 weeks, indicating the long-term
storage stability and better reproducibility.
Sensors 2020, 20, x FOR PEER REVIEW 44 of 70 
 
etc., and to establish label-free sensors [21,320]. The impedance measurements can be non-faradic or 
faradic; in other words, in the absence or presence of a redox probe. The latter measurements 
determine biochemical reactions occurring at the surface of a functionalized electrode through the 
interpretation of interfacial electron transfer resistance [320,321]. EIS converts an electrochemical 
signal response into a minute amplitude sinusoidal voltage response with respect to the frequency. 
As a result, current sine wave is generated, which changes with respect to the voltage wave and time 
(i.e., phase shift). This current to voltage ratio (V(t)/I(t)) generates an impedance (Z) [322,323]. For 
gaining the information of bio-recognition events taking place at the interface, a Randles equivalent 
circuit (i.e., simulated circuit) is generally employed for the determination of the mass-transfer 
resistance (Rmt), the charge-transfer resistance (Rct), electrolyte resistance (Rel), double-layer 
capacitance (Cdl) and Warburg impedance (W) [324]. The Bode and Nyquist plots retrieve the EIS 
information [79]. In the Bode plot, frequency is plotted against the overall impedance (|Z|). In the 
case of the Nyquist plot, the real part of impedance (Z’) versus the imaginary part of impedance (−Z’’) 
is plotted (Figure 15E) [325]. The impedimetric sensors are efficient due to their easy instrumentation, 
lucrative electrode bulk manufacturing, miniaturization ability, and remote control of the grafted 
sensors [322]. 
Bhardwaj et al. reported a label-free impedimetric-sensing strategy using GQDs to detect 
aflatoxin B1 (AFB1), a food toxin [326]. GQDs were chemically prepared on the basis of Hummer’s 
method, as depicted in Figure 25 [327]. The sensor assembly was terminated by the electrophoretic 
deposition (EPD) of hydrothermally prepared GQDs on to an ITO-coupled glass electrode, following 
an immobilization of monoclonal AFB1-antibodies using EDC-NHS chemistry. The excellent electro-
conductivity and increased surface area of the GQD sensor led to the detection of AFB1-contaminated 
maize samples in a broad linear range from 0.1 to 2.0 ng mL−1, with an LOD of 0.03 ng mL‒1. Moreover, 
the researchers declared that this sensing platform could last its activity almost up to 7 weeks, 
indicating the long-term storage stability and better reproducibility. 
 
Figure 25. (A) Preparation of GQDs. (B) Immunosensing platform for AFB1 using GQD-functionalized 
indium tin oxide (ITO)-coated glass electrode [79]. 
A functionalized‒GQDs based impedimetric antibody-sensor was established by Mehta and the 
group for quantifying a pesticide, parathion [328]. For fabricating the sensor, GQDs were embedded 
on a SPCE surface, followed by its amine functionalization through the use of 2-ABA. Subsequently, 
Figure 25. (A) Preparation of GQDs. (B) Immunosensing platform for AFB1 using GQD-functionalized
indi m tin oxide (ITO)-coated glas electrode [79].
Sensors 2020, 20, 1072 45 of 71
A functionalized-GQDs based impedimetric antibody-sensor was established by Mehta and the
group for quantifying a pesticide, parathion [328]. For fabricating the sensor, GQDs were embedded
on a SPCE surface, followed by its amine functionalization through the use of 2-ABA. Subsequently,
the treated SPCE was immobilized with the bio-receptors. This EIS sensing platform achieved a
linear array of signal response for parathion, ranging from 0.01 to 106 ng L−1 with an LOD value of
46 pg L−1 in food and environmental specimens, even in the existence of paraoxon (i.e., the metabolite
of parathion). Moreover, the authors claimed that the effective regeneration of this biosensor could be
well established for five regeneration cycles using 10 mM glycine-HCl solution.
In 2018, Elshafey and Radi designed an impedimetric MIP-based sensor for the electrochemical
determination of Alachlor (ALA), a carcinogenic herbicide found in groundwater, milk, eggs and
meat [329]. The formation of MIP film onto GCE was undertaken through the electrodeposition of
o-phenylenediamine (o-PD), where ALA was used as a template, followed by the removal of ALA to
create specific recognition cavities for ALA. The stepwise construction of the sensor was characterized
using CV, SWV and Rct, where the [Fe(CN)6]3−/4− was employed as a redox probe. The controlled
release pattern of the ALA from the MIP-o-PD network and the mole ratio of ALA to o-PD was
optimized to create a maximum number of free imprinted sites, which influenced the sensitivity of
the sensor. The increase in the Rct value of the electro-active probe [Fe(CN)6]3−/4− upon selective
accumulation of ALA to the free voids of MIP film was determined as the sensor response, where the
relative change in Rct was directly proportional to the ALA concentrations in a broad linear range
from 1 nM to 1 µM, with an LOD value 0.78 nM ALA.
Employing an aptamer proximity-binding assay approach, Ghanbari et al. introduced an
electrochemical aptasensor based on the functionalization of GCE surface by GQDs for the quantification
of the hepatitis C virus (HCV) core antigen [330]. GQDs served as an appropriate substrate for
aptamers via pi–pi stacking interactions to enrich the aptamer absorption on the GCE surface. Surface
functionalization at each stage was characterized by EIS, CV and DPV, where the EIS technique was
also used for efficiently determining HCV core antigen in human serum samples, which exhibited
the detection limit of 3.3 pg mL−1 and a wide linear relationship ranging from 1 to 400 pg mL−1 HCV
concentration. Later, in 2018, the same group had proposed another aptasensor based on thiolated
GQDs (GQDS–SH) and AuNPs for sensing streptomycin (STR) [331]. In this study, a GQD–SH was
integrated onto the surface of a GCE, followed by the decoration of AuNPs on to the thiol groups of
GQDs via the formation of an Au–S bond. At the same time, aptamers were injected onto the GCE
surface by interacting with the thiol groups of an aptamer and then a sample containing STR was
incubated, resulting in an aptamer/STR complex formation. The proposed nanoaptasensor could detect
STR by EIS in a broad linear range from 0.1 to 700 pg mL−1, with an LOD of 0.033 pg mL−1.
In 2019, Ganganboina and co-workers fabricated a label-free antibody-sensor using N,S–GQDs
and gold-embedded polyaniline (Au-PANI) nanowires for the sensitive and selective identification
of CEA [332]. N,S–GQDs served as the bifunctional probe to immobilize anti-CEA and to improve
the electrochemical performance. Figure 26 indicates the deposition of Au-PANI onto the Pt
electrode, followed by the lamination of N,S–GQDs onto the Au-PANI surface through the Au-thiol
bond. The change in impedance of Au-PANI/N,S–GQDs in the presence of CEA suppressed the
electron transfer due to the immunoreaction between CEA and its specific antibody on the surface
of Au-PANI/N,S–GQDs. This label-free antibody sensor provided a broad linear range of CEA
concentration from 0.5 to 1000 ng mL−1 with an LOD of 0.01 ng mL−1. In 2019, another impedimetric
immunosensor exploring the use of these nanomaterials, i.e., N,S–GQDs and Au-PANI nanowires,
was constructed by Chowdhury and colleagues for quantifying hepatitis E virus (HEV) [333]. Herein,
the WE was implanted with Au-PANI nanowires and N,S–GQDs by a self-assembly and an interfacial
polymerization strategy. The Au-PANI/N,S–GQDs nanocomposite was covalently immobilized by
anti-HEV and an external electrical pulse was induced during the injection of the HEV antigen to boost
sensitivity towards the target virus due to the surface expansion of the virus as well as to increase the
length of the anti-HEV-assembled polyaniline chain. This EIS biosensor could efficiently determine
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and distinguish various HEV genotypes from human serum and from fecal samples of a HEV-infected
monkey, with the LOD values of 96.7 RNA copies mL−1 and 0.8 fg mL−1, respectively. Surprisingly,
this sensor could display identical sensitivity to that exhibited by a real-time quantitative reverse
transcription polymerase chain reaction (RT-qPCR).Sensors 2020, 20, x FOR PEER REVIEW 46 of 70 
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Altintas [79].
Ye et al. demonstrated an impedimetric immunosensor for the sensitive detection of Salmonella
typhimurium [334]. Figure 27 portrays a biosensor set-up that comprises of a nanoporous alumina
membrane and a polydimethylsiloxane (PDMS) chamber, where the detection of S. typhimurium was
influenced by the variation in impedance through the membrane. When the membrane was clogged
by the accumulation of S. typhimurium, impedance increased, followed by the decrease in impedance
and death of the bacteria due to the introduction of antibiotics. Hence, this capture/sensing strategy
was examined to quantify the target bacteria as well as to examine the response of target bacteria
toward antibiotics. In the sensor development, modified GQDs were used to enhance the efficiency
of the membrane by increasing its surface/volume ratio. Subsequently, anti-Salmonella antibodies
were immobilized onto the membrane enriched with GQDs using glutaraldehyde as a cross-linking
agent, which could detect S. typhimurium within just 10 min, and provided an LOD of 1 pM. Moreover,
it was proved that this EIS sensor was extremely specific for S. typhimurium with a negligible response
to other acteria, suggesting its convincing clinical application even in the case of various other
bacterial infec ions.
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Tuteja et al. developed a label-free impedimetric immunosensor for sensing cardiac myoglobin
(cMyo) [77], a major biomarker for the detection of MI [335]. In this work, GQDs were hydrothermally
synthesized and implanted on screen-printed electrodes (SPEs) as an immobilized template.
Subsequently, SPEs were incubated with the anti-cMyo antibodies to sensitively detect the cMyo.
The modified SPEs displayed a wide range of 0.01–100 ng mL−1 and the detection limit was observed
to be 0.01 ng mL−1 (i.e., >400 fold in comparison to the conventional enzyme-linked immunosorbent
assay (ELISA) tests).
Beta-blockers (BB) are generally used as prophylactic drugs for atrial fibrillation (AF), which is
common during open heart surgery [336]. Despite a number of studies during the last few years,
satisfactory prevention of AF in individuals suffering from post-coronary artery bypass graft surgery
(CABG) has not flourished through the use of these BB. The relation between AF and elevated C-reactive
protein (CRP) levels is still contentious, if high plasma CRP concentrations are responsible for the cause
of AF, or if the elevated CRP concentration is the reason behind the existence of this disorder [337,338].
Bing and team exploited the role of GQDs as a GCE enhancer to fabricate an efficient impedimetric
antibody sensor for determining CRP in human plasma, particularly in case of clinical AF after
CABG [339]. The stepwise fabrication of the GCE surface was characterized by the EIS technique and
the target-specific Rct values displayed a wide linear logarithmic CRP concentration in the range of
0.5–70 nM, with an LOD of 176 pM.
4. Photoelectrochemical and Miscellaneous GQD Sensors in Biomedical Diagnostics
According to our statistical analysis, only a few studies have recently reported on
photoelectrochemical (PEC) GQD sensors in comparison to optical and electrochemical sensors.
At the same time, various studies have been carried out using SPR sensors for drug monitoring and
disease detection [340–343], but surprisingly only two such studies have reported on the use of GQDs.
Given this, despite SPR sensors being optical sensors, we have compiled them in this section. Also,
the biosensors like lab on chip [344], microfluidic [345], colorimetric, piezoelectric or quartz crystal
microbalance (QCM) [346] and resonance light scattering (RLS)-based sensors are still under-developed.
In spite of the versatility of piezoelectric sensors, no GQDs-based QCM sensor has been reported so far.
Among these sensors, those working under the principle of PEC are still comparatively well studied.
Therefore, we initiate the discussion of this section with PEC sensors, followed by the other sensors.
The PEC biosensing strategy originated from electrochemical techniques, which mainly involves
the photoelectric conversion process as well as the influence of light on interface materials or
photoelectrodes [347,348]. Photoelectrochemistry seems to be an interesting research hotspot because
of its prominent attention from scientists, owing to its cost-effectiveness, rapid analytical response,
easy miniaturization, simple instrumentation, exhibition of significantly low background signals and
desirable sensitivity [349–352]. The PEC biosensors work on the principle of photocurrent signal that
is generated during the binding event taking place between the target analyte and bioreceptor, which
is associated with the energy and charge transfer of the PEC reaction upon light irradiation between
the photoactive element and electron donor/acceptor moieties [351]. The photocurrent generation
mechanism primarily depends on the photoexcitation of photoactive materials, which subsequently
transfers electrons to the conduction band from the valence band. In turn, the desired pairing of an
electron-hole pair resulted, followed by the elimination of conduction-band electrons and an anodic
photocurrent signal is produced [349]. Nonetheless, the research on its detection mechanism still lies
at ground level and thus, it needs to be further explored.
In 2018, a PEC immunosensor for determining cTnI levels was engineered using CdS and N,S-GQDs
co-sensitized solvothermally strategized cube of Zn2SnO4 (Figure 28) [353]. This Zn2SnO4 cube could
effectively enhance the ITO electrode’s surface for the further modifications. N,S-GQDs were then
implanted to the Zn2SnO4 cube that boosted the electronic transferability as well as photo-to-current
convertibility. Thereafter, CdS nanoparticles were functionalized to obtain CdS/N,S-GQDs/Zn2SnO4
film. During the specific recognition of cTnI, the immunoreaction between cTnI and anti-cTnI decreased
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the photoelectric signal intensity from 0.001 to 50 × 10−9 g mL−1 of cTnI concentrations, which revealed
an LOD of 0.3 × 10−12 g mL−1. Furthermore, the authors claimed that this PEC sensor could exhibit
successful outcomes in MI diagnosis.Sensors 2020, 20, x FOR PEER REVIEW 48 of 70 
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Another PEC immunosensor was reported by Tian et al. using GQDs conjugated with the
oriental construction of silicon nanowires (SiNWs) to test microcystin-Leucine-Arginine (MC-LR),
a toxic heptapeptide found in H2O2 samples [354]. A biocompatible nanoscaffold was engaged to
immobilize the antibody as well as a SiNWs/GQD hetero-structure for signal transduction. The results
obtained showed that the SiNWs/GQD system could perform well for specifically recognizing MC-LR,
ranging from 0.1 to 10 µg L−1, with an LOD of 0.055 µg L−1, where the presence of MC-LR influenced
the optoelectronic features of the as-functionalized surface of electrode. Hence, this sensor led to
suppressed photocurrent signal intensity.
In 2018, Ahmed and co-workers demonstrated an optoelectronic immunosensing platform using
gold nanobundles (AuNBs) and GQDs for detecting fowl adenoviruses (FAdVs) [355]. This strategy
employed a sequential layer-by-layer (LbL) process for casting an AuNBs layer on carbon electrode
system through the use of gold chloroauric acid, poly-l-lysine (PLL) and L(+) ascorbic acid.
The nanohybrid comprised of GQDs and AuNBs coupled with anti-FAdVs receptors prior to quantifying
the target virus. On injecting the FAdVs antigens, an amplified signal provided upto 10 pfu mL−1
of the target analyte with an LOD of about 8.8 pfu mL−1. This immunoassay could yield excellent
sensitivity (i.e., more than 100 times) as compared to the standard ELISA tests.
In 2017, Ge at al. designed a PEC biosensor for expressing N-glycan, depending on the properties
offered by nanogold-conjoined mesoporous silicon NPs (GMSNs) fused with localized SPR and
GQDs [356]. In the development of a desired sensor, porous zinc oxide (ZnO) spheres were integrated
on the Au nanorod-functionalized paper WE and were modified with the assistance of CdTe QDs.
Subsequently, the immobilization of GMSNs onto CdTe QDs was conducted. Moreover, with the help
of localized SPR, CdTe QDs were activated and the photocurrent efficacy was amplified. Thereafter,
the multibranched hybridization chain reaction (mHCR) products to bind with HRP enzyme and to
capture the target biomolecules were implanted on the surface of the WE, which resulted in exciting
photoactive substances for facile instrumentation via a CL emission. Moreover, an aptamer could
specifically capture the cancerous cells by its ability to recognize cells that ignored the conventional
routing cell counting steps. At the same time, the GQDs acted as the signal amplification elements,
exerting the process of N-glycan evaluation, because the H2O2 consumption and the competitive
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absorption of exciting light oxidized the luminol and the electron donor of the PEC system, respectively.
This highly sensitive biosensing platform for monitoring the N-glycan-based physiological processes
could attain an LOD of 21 cells mL−1, which can be used to examine glycomics in clinical diagnostics.
In 2019, Prado and the team constructed a PEC sensor for dopamine (DA) by exploring the activity of
GQDs assembled on a fluorine-functionalized tin oxide (FTO) glassy electrode upon bio-immobilization
of bismuth vanadate (BiVO4) [357]. Since GQDs can enhance the photocatalytic activity of BiVO4 by
eliminating the photo-induced electrons from the conduction band through quantum confinement,
the photocurrent signals generated were found to be in direct correlation with the DA concentration
from 36 nmol L−1 to 250 µmol L−1, with a quantification limit of 2.7 × 10−8 mol L−1 [21]. Another
GQD-sensor for DA detection was proposed by Yan et al., where GQDs were decorated with TiO2
nanoparticles through physical adsorption [358]. Under visible-light irradiation, these nanocomposites
revealed enhanced PEC signal amplification, i.e., it increased almost 12 times and 30 times when
compared to GCE/TiO2 and GCE/GQDs, respectively. This can be ascribed to the combined additive
effect of GQDs and TiO2. Moreover, the photocurrent of these nanocomposites was elevated with the
increase in DA concentrations from 0.02 to 105 µM and offered an LOD of 6.7 nM.
In 2018, a PEC technique was established for quantifying zeatin, a cytokinin governing
plant cell differentiation and proliferation [359]. As depicted in Figure 29, this method was
coupled with streptavidin, graphite-like carbon nitride (g-C3N4), GQDs, AuNPs as well as a DNA
biotin-labeled aptamer as PEC inhibition factor, photoactive reagent, photo-activity enhancing element,
immobilization substrate for the DNA probe as well as zeatin recognition and streptavidin capture
material, respectively. In this work, the DNA aptamer could bind to zeatin for the complex formation
to liberate the aptamer from the electrode and decreased the capture amount of streptavidin, producing
an enhanced PEC signal intensity. This DNA aptasensor could show a broad linear response from
0.1 to 100 nM zeatin concentration and attained an LOD value of 0.031 nM. Additionally, this technique
could easily discriminate zeatin analogues in biological samples, suggesting its high selectivity.
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Figure 29. Design of a PEC aptasensor for zeatin determination using GQDs, AuNPs, g-C3N4 and
DNA biotin-labeled aptamer [359].
Another PEC aptasensor for chloramphenicol (CAP) identification was introduced by employing
a label-free aptamer and N-GQDs as bio-recognition and transducer elements, respectively [360].
Hydrothermally synthesized N-GQDs were exploited to generate an amplified photon-to-electron
convertibility under visible-light irradiation. Moreover, the pi-conjoined rigidity of N-GQDs could
exhibit an improvised surface to immobilize an aptamer through pi-pi bond. This N-GQDs-aptasensor
responded linearly from 10 to 250 nM of the CAP amount with a minimum quantification limit of 3.1 nM.
Recently, Ramdzan et al. designed an SPR sensor using chitosan and carboxyl-functionalized
GQDs [361]. The existence of C=O, C–O, C–H and O–H bonds in a thin film comprising GQDs and
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chitosan was confirmed by FT-IR spectra, while its optical characteristics were approved by UV–Vis
and PL spectroscopy. The PL spectra not only revealed the high absorbance value of chitosan/GQDs
film with an optical band gap of 4.012 eV, but also gave an idea about the emission of red light
because of the absorption peak appearing between 725 to 775 nm, which corresponded to pi→pi*
transitions of C=O bond. This GQD-based SPR sensor was employed for the detection of Hg2+
contaminants, which could respond to Hg2+ in a linear fashion between 0 to 100 ppm, with an
LOD value of 0.5 ppm. Figure 30 outlines the general instrumentation that works on the SPR
principle. In 2019, Sadrolhosseini et al. developed a biosensor based on the principle of SPR, where
polypyrrole-chitosan/GQDs was electrodeposited on a gold-coated glass chip [362]. The as-formed
film was characterized by FE-SEM as well as XRD and the sensor could quantify glucose, fructose as
well as sucrose. It was found that the sensor exhibited higher sensitivity for glucose than for fructose
and sucrose. The authors reported that the detection limit of about 1 ppm was estimated for these
sugars and the device could sense them within just 5 min.
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Figure 30. Schematic representation of an surface plasmon resonance (SPR)sensor. Adapted from
Ramdzan et al. [361].
Using the RLS technique, an enzyme-free GQD-sensor was constructed in 2019 [363]. In this study,
a catalytic hairpin assembly amplification approach was used for detecting p53 mutant DNA. Figure 31
pictures the development of this strategy with two probes comprising GQDs and hairpins in each
(i.e., GQDs-H1 and GQDs-H2). Two partially complementary hairpins (i.e., H1 and H2) were so aptly
framed that they could not undergo concurrent hybridization, when the target DNA is not present.
As soon as the target DNA was introduced, it could bind with GQDs-H1 followed by the formation
of GQDs-H1: target intermediates. Subsequently, GQDs-H2 could fuse with GQDs-H1, resulting in
another reaction cycle. The generation of an increased RLS signal intensity could be ascribed to the
aggregation of GQDs-H1 and GQDs-H2. This RLS-sensor could identify p53 mutant DNA in a broad
range from 1 pmol L−1 to 50.0 nmol L−1, with the detection limit of 0.8 pmol L−1. Another RLS-sensor
was reported by Wu et al. In 2017 [364]. The GQDs were selected as probes to fabricate this sensor
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for tracing proteins. According to the electrostatic interaction taking place between proteins and
GQDs, the RLS signal was elevated, because of the incorporation of proteins in the GQDs solution.
This RLS-sensor could provide a linear response, ranging from 10 µM to 60 µM protein concentration
and an LOD of 2.4 µM.
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assembly amplification appr ach [363].
Liu and team introduced a microfluidic paper-based approach for CA 15-3 biomarker
quantification [365]. Au nanocages we e deposited on the surface of a paper working electrode
(PWE) for l ading primary anti-CA 15-3 antibodies. Using the ECL technique and by immobilizing
labeled secondary antibodies to establish a sandwich assay, the det ction of a target analyte was
ac mplished. The characterization of the sen or surfac was d ne using SEM, which revealed that
the filamentous morphology of Au nanocages allowed more GQDs to be accumulated, permitting
an increased ECL inte sity. The as-devel p d sen or could offer a dynamic linearity over th range
of 0.005–500 U mL−1 CA 15-3, with a quantificatio limit of 0.0014 U mL−1. Moreover, Li et al. also
proposed a microfluidic p per-based sensing tool, where they explored the role of GQDs, concanavalin A
and Au@Pd alloy NPs t set-up an ass mbly by layer-by-layer modifi tion appro ch [366]. This device
c uld efficiently sense H2O2 that oozed out from ca cer cells on the basis of an in sit hydroxyl radicals
cleaving DNA stra egy, a hieving an LOD down to 0.05 nmol.
To the best of our kn wledge, the very first multifunctional GQD sensor based on the principle
of colorimetry was inve ted by Park et al. In 2015 [367]. This biosensor involved the use of block
polymer-implanted GQDs (bcp-GQDs), which generated var ation in luminescence with respe t
to the change in pH and temperature that del vered the dose-dependent relationship corresponding
o the distinct metal ions. This s nsing platform could detect F 3+ conce trations in a linear rang
of 0-50 µM. In the same year, Lin and coworkers developed an N-GQDs-based colorimetric sensor
for monitoring H2O2 and glucose levels [368]. The linear regression function could lie ver the
range of 20-1170 µM for H2O2 and 25-375 µM for glucose, with LOD values of 5.3 µM and 16 µM
for H2O2 and glucose, respectiv ly. T e authors rep rted that this method can be used to check
the glucose contents in human serum as well as in fruit juice. As illustrated in Figure 32, another
colorimetric sensor was proposed for H2O2 determination, where AgNPs and GQDs were employed
for its velopment [369]. The GQD /AgNPs nanocomposite showed an excellent absorbance-fading
response for H2O2 reduction. This colorimetric sensing platform was further applied for glucose
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detection based on the catalytic activity of glucose oxidase to oxidize and form glucose and H2O2,
respectively. Such a sensing system could detect H2O2 as well glucose in the respective ranges of
0.1−100 µM and 0.5−400 µM, where the corresponding LOD values were reported as 33 nM and
170 nM. On the other hand, Nirala et al. presented a GQD-based colorimetric sensor for cholesterol
detection [370]. Owing to the electro-catalytic activity offered by the GQDs in the presence of H2O2,
a color change of a solution containing TMB was observed from transparent to blue. This sensing
mechanism could deliver the quantification of cholesterol over a wide range from 0.02 to 0.6 mM, with
an LOD of 0.006 mM.
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5. Summary, Critical Issues and Future Directions
Nanomaterials like GQDs, alone or when conjoined with numerous other nanomaterials to form
hybrid nanocomposites, exhibit marvelous features by virtue of their unique characteristics and/or their
desired synergism for fabricating biosensors. Over the past decade, these biosensing platforms offered
a plethora of opportunities to diagnose a wide range of diseases from autoimmune, neurodegenerative,
cardiovascular and infectious diseases to cancer diagnosis. In association with the degree of particularity
in the case of these pathophysiologies, their early detection via the use of disease biomarkers, toxins
and pathogens in biological, environmental or/and food samples illustrates significant and concrete
ideas about their severity. The sensitivity, selectivity, accuracy and reliability of the disease-associated
molecules seem to be still challenging because of their ultralow concentrations. Nonetheless, it is
evinced from our review article that the GQD-based sensors have now conspicuously accomplished the
minimum limit of sensing certain target biomolecules. These biosensors for early disease detection have
gained meticulous popularity in many sectors such as clinical therapy, disease monitoring, discovery
of preventive therapies as well as in the development of treatment-based medicines.
In this review, we examined research works conducted especially in last 5 years, highlighting
the fascinating contribution of GQDs in introducing biosensors owing to their extraordinary and
multifarious properties, i.e., good electro-catalytic activity, excellent fluorescence attributes, abundant
modification sites, enhanced electro-conductivity, ability to amplify sensor signals, edge-effects, size
effects, photo-stability, etc. Therefore, GQDs stand in such a position that they can easily functionalize
several bio-electrodes, permitting quick, simple, stable, reproducible as well as lucrative sensing
systems for clinical and practical applications. Moreover, these GQD-sensors are quite renowned for
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their excellent specificity, superior selectivity, and sensitivity in biological matrices including human
blood, urine, sputum, saliva, milk, hard water, soil, etc., which can be ascribed to the physical and
chemical attributes of GQDs.
Contradictorily, the involvement of costlier nanomaterials in combination with GQDs, laborious
assay methodologies, insufficient storage stability and a number of displeasing factors at the nanoscale
level are some obstructions that act as hurdles for their bulk manufacture. Additionally, most of these
sensors reported very recently are not yet validated for their clinical applicability. Hence, strategies for
establishing bulk batches of sensors and achieving their mass production as well as their approval in
the real world have to be developed.
As far as our detailed and comprehensive literature survey is concerned, more than 80% of
GQD-based sensors for biomedical applications have been reported from 2015 onwards, which
suggests that GQD sensors represent one of the hottest emerging research topics. In terms of the overall
statistics regarding the studies associated with GQD biosensors, to the best of our knowledge nearly
52%, 40% and 4% of the research works have been carried out to develop optical, electrochemical
and photoelectrochemical biosensors, respectively. This can be credited especially to the mesmerizing
fluorescent and electro-catalytic characteristics of GQDs. Surprisingly, only 4% of research works are
based on other GQD sensors in total (i.e., piezoelectric, RLS-dependent, microfluidic paper-based and
colorimetric sensors). Presumably, the substantial role of GQDs to construct biosensors for the clinical
diagnosis of certain diseases will be developed in the near future.
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